Elizabeth Ayn Evans - UMass

January 2021

Elizabeth A. Evans

312 Arnold House, 715 North Pleasant Street

University of Massachusetts Amherst, Amherst, MA 01003 Tel: 413-545-4434 Email: [email protected]

ResearcherID: T-8683-2018 ORCID: 0000-0002-3478-9957

EDUCATION

Ph.D. University of California, Los Angeles (UCLA), 2010-2016

Fielding School of Public Health, Department of Community Health Sciences

M.A. Indiana University, Bloomington, 1994-1995

Comparative Literature

B.A. University of California, San Diego (UCSD), 1993 Literature, Political Science

Study abroad in Florence, Italy

PROFESSIONAL RESEARCH POSITIONS

2020 – present Associate Professor of Community Health Education, Department of Health Promotion

and Policy, School of Public Health and Health Sciences, University of Massachusetts,

Amherst, MA

2017 – 2020 Assistant Professor of Community Health Education, Department of Health Promotion

and Policy, School of Public Health and Health Sciences, University of Massachusetts,

Amherst, MA

2020 – present Co-Facilitator, Institute for Social Science Research (ISSR) Scholars Program,

University of Massachusetts, Amherst, MA

2020 – present Founder and Director, Holyoke District Court HEART Program Internship, University of Massachusetts, Amherst, MA

2017 – present Adjunct Fellow, Institute for Healthcare Delivery and Population Science, University of

Massachusetts Medical School-Baystate, Springfield, MA

2017 – present Research Scientist (without compensation, WOC), VA Central Western Massachusetts Healthcare System, Leeds, MA

2016 – 2017 Advanced Postdoctoral Research Fellow, Center for the Study of Healthcare Innovation,

Implementation and Policy (CSHIIP), Health Services Research and Development (HSR&D), U.S. Department of Veterans Affairs, Los Angeles, CA

1999 – 2016 Project Director, UCLA Semel Institute for Neuroscience and Human Behavior, Los

Angeles, CA

2013 – 2015 Health Scientist, Centre for Health Excellence in HIV/AIDS, University of British Columbia, Vancouver, Canada

2007 – 2008 Health Scientist, School of Public Policy, Pepperdine University, Malibu, CA

1990 – 1994 Research Assistant, Criminal Justice Research Division, San Diego Association of Governments (SANDAG), San Diego, CA

mailto:[email protected]

CV for Evans, E. January 2021

Page 2 of 29

HONORS

2011, 2012, 2013 Charles F. Scott Fellowship, UCLA ($45,000 over 3 years)

2010 UCLA Graduate Division, University Fellowship ($10,000)

2010 UCLA Staff Assembly Professional Development Scholarship ($500)

AWARDS

2019 Distinguished Community Engagement Award for Research, Office of the Provost, University of

Massachusetts Amherst ($1,000 – donated to non-profit community partner)

2019 Institute for Social Science Research (ISSR) Scholar. College of the Social and Behavioral Sciences, University of Massachusetts Amherst

2018 Public Engagement Faculty Fellow. Public Engagement Project (PEP), University of

Massachusetts Amherst ($1,500) 2018 Travel award, National Institute on Drug Abuse (NIDA) Women & Sex/Gender Differences

Junior Investigator, June 9-14, 2018 meeting of the College on Problems of Drug Dependence

(CPDD) ($1,000) 2016 Travel award, National Institute on Drug Abuse (NIDA) Women & Sex/Gender Differences

Junior Investigator, June 13-15, 2016 meeting of the College on Problems of Drug Dependence

(CPDD) ($1,200)

2015 Travel award, National Institute on Drug Abuse (NIDA) Women & Sex/Gender Differences Junior Investigator, June 13-15, 2015 meeting of the College on Problems of Drug Dependence

(CPDD) ($1,200)

2015 Junior Investigator Travel award, American Psychological Association (APA) Division 28 and 50, August 6-9, 2015, Toronto ($1,000)

2013 Travel award, National Institute on Drug Abuse (NIDA) International Conference on Global

Health: Prevention and Treatment of Substance Abuse and HIV, Taipei, Taiwan ($2,000) 2012 Travel award, National Institute on Drug Abuse (NIDA) Addiction Health Services Research,

New York ($1,500)

2012 Travel award, University of California Global Health Day, UC Berkeley, California ($1,000)

PROFESSIONAL DEVELOPMENT

2019 Yale University Interdisciplinary Center for Bioethics, Foundations of Bioethics. June 11-14, 2019.

2018 Professional development award, “Exploring narrative medicine for behavioral health: pedagogy and

practice.” Dean of the School of Public Health and Health Sciences, University of Massachusetts Amherst. ($3,000)

2017 Trained Facilitator. NRMN Train-the-Trainers Workshop: Facilitating Entering Mentoring.

GRANTS AND CONTRACTS – ACTIVE SINCE 2017 - $14.4 MILLION

A statewide evaluation of the implementation of medications for opioid use disorder in Vermont

correctional facilities and the impact of COVID-19. PI: Klemperer. Co-Is: Rawson, Brooklyn. Sponsor:

Evans. NIH National Institute on Drug Abuse (NIDA) JCOIN JRIG. 10/1/20 – 9/30/22. $99,931.

Community Opportunity, Network, Navigation, Exploration, and Connection Team-CONNECT. Substance

Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment

(CSAT), CARA FOA #TI-19-004. $2 million with evaluation subcontract to PI Evans. 08/20-07/22. Awarded 10/9/20.


Page 3 of 29

Massachusetts Justice Community Opioid Innovation Network (Mass JCOIN). mPIs: Friedmann and Evans. NIH National Institute on Drug Abuse (NIDA). Grant No. 1UG1DA050067-01 $10,090,778.

9/1/19 – 8/30/24. Awarded.

The Franklin County Sheriff’s Office MAT Reentry Initiative. Substance Abuse and Mental Health

Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT). Grant No.

1H79T1081387-01. $1.5 million with $265,602 evaluation subcontract to PI Evans. 10/18-9/21. Awarded.

Exploring Shared Decision-making as an Ethical Response to the Opioid Epidemic. The Greenwall

Foundation, Making a Difference Program. PI: Evans. 07/18 – 06/20. $128,164. Awarded.

SHIFT Care. Massachusetts Health Policy Commission. Behavioral Health Network and Holyoke Health

Center. Evaluation subcontract to PI: Geissler, Co-I: Evans. 07/18 – 06/20. $50,000. Awarded.

Post-Release Opioid Use Trajectories after MAT in Jail. Administrative supplement to Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE). National Institute on

Drug Abuse (NIDA). Grant No. 3UG3DA044830-02S1. PI Friedmann. Co-I Evans. 08/01/18-07/30/20

(NCE). $359,907 with $196,103 subaward to Evans. Awarded.

Evaluation of the Massachusetts Public Health Data Warehouse. Massachusetts Department of Public

Health Office of Population Health. PI: Evans. 10/01/18-06/30/19. $50,000. Awarded.

Cannabis Legalization Impacts in Massachusetts: State of the Data. Massachusetts Department of Public

Health, Cannabis Control Commission. PI: Whitehill. Co-Is Evans and Geissler. 01/19 – 06/19. $50,860.

Awarded.

Adapting digital storytelling methods for women with opioid use disorders to improve medication assisted

treatment utilization and strengthen community integration. University of Massachusetts Worcester Center for Clinical and Translational Science (UMCCTS) Community Research Innovative Scholars Program

(CRISP) Award. National Institutes of Health grant number UL1TR001453. PI: Evans. 04/18 – 03/19.

Total amount: $15,000. Awarded.

A mixed methods approach to understanding gender differences in behavioral and pain responses to complementary and integrative health (CIH/CAM) in military veterans. Iris Cantor-UCLA National Center

of Excellence in Women’s Health. NCATS UCLA CTSI grant number UL1TR001881. PI: Evans. 08/17 –

07/18. Total amount: $20,000. Awarded.

Adapting digital storytelling methods with and for homeless women Veterans to improve community

integration by supporting self-management of substance abuse recovery. Veterans Affairs Office of

Rehabilitation Research and Development. PI: Evans. 02/17 – 09/17. Total amount: $9,000. Awarded.

PUBLICATIONS Google Scholar: 3,189; h-index 32; i10-index 62

35% first-authored, in 30+ different journals. *mentorship of a student, pre- or post-doctoral scholar, or

fellow

1. Evans, E., Stopka, TJ, Pivovarova, E, Murphy, SM, Taxman, FS, Ferguson, WJ, Bernson, D,

Santelices, C, McCollister, KE, Hoskinson, R, Lincoln, T, Friedmann, PD. (2021). Massachusetts Justice Community Opioid Innovation Network (Mass JCOIN). Journal of Substance Abuse

Treatment. In press.

2. Donelan, CJ, *Hayes, E, Potee, R, Schwartz, L, Evans, E. (2020). COVID-19 and treating

incarcerated populations for opioid use disorder. Journal of Substance Abuse Treatment. In press. 3. Evans, E., *Delorme, E., Cyr, K, Goldstein, D. (2020). A qualitative study of big data and the opioid

epidemic: Recommendations for data governance. BMC Medical Ethics, 21(1), 1-13.


Page 4 of 29

4. Evans, E., Harrington, C., Roose, R., *Lemere, S., Buchanan, D. (2020). Perceived benefits and harms of civil commitment for opioid use disorder. Journal of Law, Medicine, and Ethics. In press.

5. Evans, E., Goldwater, E., Stanek, E., Brierley-Bowers, P., Buchanan, D., Whitehill, J. (2020).

Prevalence and correlates of cannabis use in Massachusetts after cannabis legalization and before

retail sales. Journal of Drug Issues. E-pub online. 6. Evans, E., Goff, S., Upchurch, D., Grella, C. (2020). Childhood adversity and mental health

comorbidity in men and women with opioid use disorders. Addictive Behaviors. 102:106149.

PMCID: PMC7405712. 7. Geissler, K.H. & Evans, E.A. (2020). Changes in Medicaid acceptance by substance abuse treatment

facilities after federal parity laws. Medical Care. 58(2):101-107. PMID: 31688556.

8. Evans, E., *Yoo, C., Huang, D., Saxon, A.J., Hser, Y.I. (2019). Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results

from a multisite randomized trial of patients with opioid use disorder. Journal of Substance Abuse

Treatment. 106:19-28. PMCID: PMC6756169.

9. Evans., E., *Zhu, Y., *Yoo, C., Huang, D., Hser, YI. (2019). Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder.

Addiction. 114 (8): 1396-1404. PMCID: PMC6626574.

10. Evans, E., *Tennenbaum, D. L., Washington, D., Hamilton, A. (2019). Why women Veterans do not use VA-provided health and social services: Implications for healthcare design and delivery.

Journal of Humanistic Psychology. In press.

11. *Zhu, Y., Evans, E., Mooney, L., Saxon, A., *Kelleghan, A., *Yoo, C., Hser, YI. (2018). Correlates of long-term opioid abstinence after randomization to methadone versus buprenorphine/naloxone in a

multi-site trial. Journal of Neuroimmune Pharmacology. 13(4):488-497. PMCID: 6224303.

12. Evans, E., Herman, P., Washington, D., Lorez, K.A., Yuan, A., Upchurch, D.M., Marshall, N.,

Hamilton, A.B., & Taylor, S.L. (2018). Gender differences in use of complementary and integrative health by U.S. military veterans with chronic musculoskeletal pain. Women’s Health Issues.

28(5):379-386. PMCID: 6699154.

13. Evans, E., *Glover, D., Washington, D., & Hamilton, A. (2018). Psychosocial factors that shape the health of women Veterans who use community-based social services. Substance Use & Misuse,

53(11): 1878-1892.

14. Evans, E., Upchurch, D., Simpson, T., Hamilton, A., & Hoggatt, K. (2018). Differences by

Veteran/civilian status and gender in associations between childhood adversity and alcohol and drug use disorders. Social Psychiatry and Psychiatric Epidemiology, 53(4):421-435.

15. Krebs, E., Enns, B., Evans, E., Urada, D., Anglin, M.D., Rawson, R.A., Hser, Y.I., & Nosyk, B.

(2018). Cost-effectiveness of publicly funded treatment of opioid use disorder in California. Annals of Internal Medicine, 168(1):10-19.

16. Wang, L., Min, J.E., Krebs, E., Evans, E., Huang, D., Liu, L., Hser, Y.I., & Nosyk, B. (2017).

Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. The International Journal of Drug Policy, 49: 32-40.

PMCID: PMC5681890

17. Krebs, E., Min, J. E., Evans, E., Li, L., Liu, L., Huang, D., Urada, D., Kerr, T., Hser, Y.I., & Nosyk,

B. (2017). Estimating state transitions for opioid use disorders. Medical Decision Making, 37(5):483-497. PMCID: PMC5536954

18. Evans, E., Grella, C., & Upchurch, D. (2017). Gender differences in the effects of childhood adversity

on risk for alcohol use disorders, drug use disorders, and poly-substance use disorders. Social Psychiatry and Psychiatric Epidemiology, 52(7):901-912.

19. Evans, E., Grella, C., Washington, D., & Upchurch, D. (2017) Gender and race/ethnic differences in

the persistence of alcohol, drug, and poly-substance use disorders. Drug and Alcohol Dependence, 174: 128-136.


Page 5 of 29

20. Krebs, E., Urada, D., Evans, E., Huang, D., Hser, Y.I., & Nosyk, B. (2017) The costs of crime during and after publicly-funded treatment for opioid use disorders: a population-level study for the state

of California. Addiction, 112(5): 838-851. PMCID: 5382102.

21. Hser, YI, Evans, E., Huang, D., Weiss, R., Saxon, A., Carroll, K.M., Woody, G., Liu, D., Wakim, P.,

Matthews, A., Hatch-Maillette, M., Jelstrom, E., Wiest, K., McLauglin, P., & Ling, W. (2016). Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-

site trial. Addiction, 111(4):695-705. PMCID: 4801718.

22. Evans, E., *Kelleghan, A., Li, L., Min, J., Huang, D., Urada, D., Hser, Y.I., & Nosyk, B. (2015). Gender differences in mortality among treated opioid dependent patients. Drug and Alcohol

Dependence. 155:228-235. PMCID: 4581957.

23. Evans, E., Padwa, H., Li, L., *Lin, V., & Hser, Y.I. (2015). Heterogeneity of mental health service utilization and high mental health service use among women eight years after initiating substance

use disorder treatment. Journal of Substance Abuse Treatment, 59:10-9. PMCID: 4661078.

24. Evans, E., Li, L., *Min, J., Huang, D., Urada, D., Lei, L., Hser, Y.I., & Nosyk, B. (2015). Mortality

among individuals accessing pharmacological treatment for opioid dependence in California, 2006 – 2010. Addiction, 110: 996–1005. PMCID: 4452110.

25. Schulte, M., Hser, Y.I., Saxon, A., Evans, E., Li, L., Huang, D., Hillhouse, M., Thomas, C., & Ling,

W. (2015). Risk factors associated with HCV among opioid-dependent patients in a multisite study. Journal of Community Health, 40(5):940-947. PMCID: 4558248.

26. Nosyk, B., Min, J., Evans, E., Li, L., Liu, L., Lima, V.D., Wood, E., & Montaner, J.S.G. (2015). The

effects of opioid substitution treatment and highly active antiretroviral therapy on the cause-specific risk of mortality among HIV positive people who inject drugs. Clinical Infectious Diseases,

61(7):1157-1165. PMCID: 4560909.

27. Hser, Y.I., Evans, E., Grella, C., Ling, W., & Anglin, M.D. (2015). Long-term course of opioid

addiction. Harvard Review of Psychiatry, 23 (2): 76-89. 28. Hser, Y.I., *Lanza, I., Li, L., *Kahn, E., Evans, E., & Schulte, M. (2015). Maternal mental health and

children’s internalizing and externalizing behaviors: Beyond maternal substance use disorders.

Journal of Child and Family Studies, 24:638–648. PMCID: 4349431. 29. Evans, E., Li., L., *Buoncristiani, S., & Hser, Y.I. (2014). Perceived neighborhood safety, recovery

capital, and successful outcomes among mothers 10 years after substance abuse treatment.

Substance Use & Misuse, 49 (11): 1491-1503. PMCID: 4116446.

30. Nosyk, B., Li, L., Evans, E., Urada, D., Huang, D., Wood, E., Rawson, R., & Hser, Y.H. (2014). Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in

publicly-funded facilities in California, US: 1991-2012. Drug and Alcohol Dependence, 143:149-

157. PMCID: 4484858. 31. Hser, Y.I., Evans, E., & Grella, C. (2014). Regional variation in the global burden of disease

attributable to opioid dependence: Where do the data come from and does population size matter?

Addiction, 109 (8): 1334-1335. 32. Evans, E., Li, L., Urada, D., & Anglin, M.D. (2014). Comparative effectiveness of California’s

Proposition 36 and drug court programs before and after propensity score matching. Crime &

Delinquency, 60(6):909-938. PMCID: 3025310. 33. Nosyk B., Li L., Evans E., Huang D., Min J., Kerr T., Brecht M.L., & Hser Y.I. (2014). Characterizing

longitudinal health state transitions among heroin, cocaine, and methamphetamine users. Drug and

Alcohol Dependence, 140:69-77. PMCID: 4072125. 34. Hser, Y., Evans, E., Li, L., *Metchik, A., & Messina, N. (2014). Children of treated substance-abusing

mothers: A 10-year prospective study. Clinical Child Psychology and Psychiatry, 19(2): 217-232.

PMCID: 3879161. 35. *Jaffe, A., Anglin, D., Evans, E., Urada, D., & Nosyk, B. (2014). Cost variation among

subpopulations of diverted drug offenders under California's Proposition 36. Journal of Alcoholism

and Drug Dependence, 2:157.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382102/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801718/

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116446/?tool=nihms%0A%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20


Page 6 of 29

36. *Jaffe, A., Anglin, D., Urada, D., & Evans, E. (2014). Jurisdictional variation in the economic impact of California's Proposition 36 drug offender diversion program. Journal of Alcoholism and Drug

Dependence, 2:158.

37. Prendergast, M., Li, L., Evans, E., & Hall, E. (2013). Consistency in self-reports of drug use frequency by high-risk offenders over a five-year interval. The Prison Journal, 93(4): 375-389. PMCID:

4145597.

38. Evans, E., Li., L., *Pierce, J., & Hser, Y.I. (2013). Explaining long-term outcomes among drug dependent mothers treated in women-only versus mixed-gender programs. Journal of Substance

Abuse Treatment, 45(3): 293-301. PMCID: 3725737.

39. Anglin, M.D., Jaffe, A., Nosyk, B., Urada, D., & Evans, E. (2013). Offender diversion into substance use disorder treatment: The economic impact of California's Proposition 36. American Journal of

Public Health, 103(6): 1096-1102. PMCID: 3698729.

40. Evans, E., Li, L., Grella, C., Brecht, M.L., & Hser, Y.I. (2013). Developmental timing of first drug treatment and 10-year patterns of drug use. Journal of Substance Abuse Treatment, 44: 271-279.

PMCID: 3519944.

41. Anglin, D., Jaffe, A., Nosyk, B., Urada, D., & Evans, E. (2013). Offender diversion into substance use disorder treatment: Demographic variation in the economic impact of California’s Proposition 36.

Journal of Alcoholism and Drug Dependence, 1: 140.

42. Nosyk, B., Sun, H., Evans, E., Marsh, D.C., Anglin, M.D., Hser, Y.I., & Anis, A.H. (2012). Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment:

Results from a population-based retrospective cohort study. Addiction, 107(9): 1621-1629.

PMCID: 3376663. 43. Evans, E., *Pierce, J., Li, L., Rawson, R., & Hser, Y.I. (2012). More alike than different: Health

needs, services utilization, and outcomes of Asian American and Pacific Islander (AAPI)

populations treated for substance use disorders. Journal of Ethnicity in Substance Abuse, 11(4): 318-338. PMCID: 3526835.

44. *Du, J., Lombardi, C., Evans, E., *Jiang, H., Zhao, M., & Meng, Y.Y. (2012). A mixed methods

approach to identifying factors related to voluntary HIV testing among injection drug users in Shanghai, China. International Journal of Infectious Diseases, 16(7): e498-503. PMCID: 3378774.

45. Hser, Y.I., *Hunt, S., *Chang, Y., Evans, E., & Messina, N. (2012). Hispanic parenting women in

women-only versus mixed-gender drug treatment: A 10-year prospective study. Addictive Behaviors, 37(6): 729-735. PMCID: 3334437.

46. Evans, E., Jaffe, A., Urada, D., & Anglin, M.D. (2012). Differential outcomes of court-supervised

substance abuse treatment among California parolees and probationers. International Journal of Offender Therapy and Comparative Criminology, 56(4): 539-556. PMCID: 3817935.

47. Hser, Y., *Du, J., Li, J., Zhao, M., *Chang, Y.J., *Peng, C.Y., & Evans, E. (2012). Hepatitis C among

methadone maintenance treatment patients in Shanghai and Kunming, China. Journal of Public Health, 34(1):24-31. PMCID: 3285118.

48. Hser, Y., *Kagihara, J., Huang, Y., Evans, E., & Messina, N. (2012). Mortality among substance-

using mothers in California: A 10-year prospective study. Addiction, 107(1): 215-222. PMCID: 3226896.

49. Hser, Y.-I., Evans, E., Huang, D., & Messina, N. (2011). Long-term outcomes among drug dependent

mothers treated in women-only versus mixed-gender programs. Journal of Substance Abuse Treatment, 41(2):115-123. PMCID: 3131445.

50. Evans, E., Huang, D., & Hser, Y.-I. (2011). High-risk drug offenders participating in court-supervised

substance abuse treatment: Characteristics, treatment received, and factors associated with

recidivism. Journal of Behavioral Health Services and Research, 38(4): 510-525. PMCID: 3170514.

51. Hser, Y.I., Li, J., Jiang, H., Zhang, R., *Du, J., Zhang, C., Zhang, B., Evans, E., *Wu, F., *Chang,

Y.J., *Peng, C., Huang, D., Stitzer, M.L., Roll, J., & Zhao, M. (2011). Effects of a randomized


Page 7 of 29

contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction, 106(10): 1801-1809. PMCID: 3174353.

52. Huang, D.Y.C., Evans, E., *Hara, M., Weiss, R.E., & Hser, Y.I. (2011). Employment trajectories:

Exploring gender differences and impacts of drug use. Journal of Vocational Behavior, 79(1): 277-

289. PMCID: 3134335. 53. Evans, E., Anglin, M.D., Urada, D., & *Yang, J. (2011). Promising practices for delivery of court-

supervised substance abuse treatment: Perspectives from six high-performing California counties

operating Proposition 36. Evaluation and Program Planning, 34: 124-134. PMCID: 3025310. 54. Evans, E., Grella, C., Murphy, D., & Hser, Y.-I. (2010). Using administrative data for longitudinal

substance abuse research. Journal of Behavioral Health Services & Research, 37 (2): 252-271.

PMCID: 2850956. 55. Li, L., Evans, E., & Hser, Y.-I. (2010). A marginal structural modeling approach to assess the

cumulative effect of drug treatment on later drug use abstinence. Journal of Drug Issues, 40 (1):

221-240. PMCID: 3090640. 56. Prendergast, M., Huang, D., Evans, E., & Hser, Y.-I. (2010). Gender differences in arrest trajectories

among adult drug abuse treatment participants. Journal of Drug Issues, 40 (1): 7-26. PMCID:

2967037.

57. Evans, E., Hser, Y.-I., & Huang, D. (2010). Employment services utilization and outcomes among substance-abusing offenders participating in California’s Proposition 36 drug treatment initiative.

Journal of Behavioral Health Services & Research, 37 (4): 461-476. PMCID: 2895690.

58. Evans, E., Li, L., & Hser, Y.-I. (2009). Client and program factors associated with dropout from court mandated drug treatment. Evaluation and Program Planning, 32 (3): 204-212. PMCID: 2703685.

59. Brecht, M.L., Stein, J., Evans, E., Murphy, D., & Longshore, D. (2009). Predictors of intention to

change HIV sexual and injection risk behaviors among heterosexual methamphetamine-using offenders in drug treatment: A test of the AIDS risk reduction model. Journal of Behavioral Health

Services and Research, 36 (2): 247-266. PMCID: 3695827.

60. Evans, E., Murphy, D., Grella, C., *Mouttapa, M., & Hser, Y.-I. (2008). Regulatory issues

encountered when conducting longitudinal substance abuse research. Journal of Drug Issues, 38 (4): 1003-1026. PMCID: 2850543.

61. Evans, E., Li, L., & Hser, Y.-I. (2008). Treatment entry barriers among California’s Proposition 36

offenders. Journal of Substance Abuse Treatment, 35 (4): 410-418. PMCID: 2576498. 62. Hser, Y.-I., Evans, E., Huang, D., Brecht, M.L., & Li, L. (2008). Comparing the dynamic course of

heroin, cocaine, and methamphetamine use over 10 years. Addictive Behaviors, 33 (12): 1581–

1590. PMCID: 2850956.

63. Brecht, M.L., Huang, D., Evans, E., & Hser, Y.-I. (2008). Polydrug use and implications for longitudinal research: Ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug

and Alcohol Dependence, 96 (3): 193-201. PMCID: 3566664.

64. Hser, Y.-I., Huang, D., Brecht, M.L., Li, L., & Evans, E. (2008). Contrasting trajectories of heroin, cocaine, and methamphetamine use. Journal of Addictive Diseases, 27 (3): 13-21. PMCID:

2821675.

65. Hser, Y.-I. & Evans, E. (2008). Cross-system data linkage for treatment outcome evaluation: Lessons learned from the California Treatment Outcome Project. Evaluation and Program Planning, 31(2):

125-135. PMCID: 2413098.

66. Murphy, D.A., Brecht, M.L., Herbeck, D., Evans, E., Huang, D., & Hser, Y.-I. (2008) Longitudinal

HIV risk behavior among the Drug Abuse Treatment Outcome Studies (DATOS) adult sample. Evaluation Review, 32 (1): 83-112. PMCID: 2538490.

67. *Fosados, R., Evans, E., & Hser, Y.-I. (2007). Ethnic differences in services utilization and outcomes

among Proposition 36 offenders in California. Journal of Substance Abuse Treatment, 33: 391-399. PMCID: 2219211.


Page 8 of 29

68. Hser, Y.-I., Evans, E., Teruya, C., Huang, D., & Anglin, M.D. (2007). Predictors of short-term treatment outcomes among Proposition 36 clients. Evaluation and Program Planning, 30: 187-196.

PMID: 17689324.

69. Hser, Y.-I., Teruya, C., Brown, A.H., Huang, D., Evans, E., & Anglin, E. (2007). Impact of

California’s Proposition 36 on the drug treatment system: Treatment capacity and displacement. American Journal of Public Health, 97(1): 104-109. PMCID: 1716257.

70. Evans, E., Spear, S., Huang, Y-C, & Hser, Y.-I. (2006). Do American Indians benefit from drug and

alcohol treatment? Treatment outcomes among American Indians in CalTOP. American Journal of Public Health, 96 (5): 889-896. PMCID: 1470575.

71. Ettner, S.L., Huang, D., Evans, E., Ash, D. R., *Hardy, M., *Jourabchi, M., & Hser, Y.-I. (2006).

Benefit-cost in the California Treatment Outcome Project: Does substance abuse treatment "pay for itself?” Health Services Research, 41 (1): 192-213. PMCID: 1681530.

72. Hser, Y.-I., Grella, C., Evans, E., & Huang, Y.-U. (2006). Utilization and outcomes of mental health

services among patients in drug treatment. Journal of Addictive Diseases, 25 (1): 73-85. PMID:

16597575. 73. Evans, E., Longshore, D., Prendergast, M., & Urada, D. (2006). Evaluation of the Substance Abuse

and Crime Prevention Act: Client characteristics, treatment completion and re-offending three years

after implementation. Journal of Psychoactive Drugs, SARC Supplement 3: 357-369. PMID: 17357527.

74. Teruya, C., Hardy, M., Hser, Y.-I., & Evans, E. (2006). Implementation of a statewide outcome

monitoring system in clinical settings: Perspectives of treatment provider staff. Qualitative Health Research, 16 (3): 337-352. PMID: 16449685.

75. Grella, C., Hser, Y.-I., Teruya, C., & Evans, E. (2005). How can research-based findings be used to

improve practice? Perspectives from participants in a statewide outcomes monitoring study.

Journal of Drug Issues, 35 (3): 465-480. 76. Hser, Y.-I., Evans, E., & Huang, D. (2005) Treatment outcomes among women and men

methamphetamine abusers in California. Journal of Substance Abuse Treatment, 28 (1): 77-85.

PMID: 15723735. 77. Evans, E. & Longshore, D. (2004). Evaluation of the Substance Abuse and Crime Prevention Act:

Treatment clients and program types during the first year of implementation. Journal of

Psychoactive Drugs, SARC Supplement 2: 165-174. PMID: 15279129.

78. Hser, Y.-I., Evans, E., Huang, D, & Anglin, D (2004). Relationship between drug treatment services, retention, and outcomes. Psychiatric Services, 55 (7): 767-774. PMID: 15232015.

79. Evans, E. & Hser, Y.-I. (2004). Pilot-testing a statewide outcome monitoring system: Overview of the

California Treatment Outcome Project (CalTOP). Journal of Psychoactive Drugs, SARC Supplement 2: 109-114. PMID: 15279122.

80. Hser, Y.-I., Teruya, C., Evans, E., Longshore, D., Grella, C., & Farabee, D. (2003). Treating drug-

abusing offenders. Initial findings from a five-county study on the impact of California’s Proposition 36 on the treatment system and patient outcomes. Evaluation Review, 27(5): 479-505.

PMID: 14531316.

81. Longshore, D., Prendergast, M., Hser, Y.-I., Evans, E. (2002). Treatment in lieu of incarceration,

evaluation of California’s Substance Abuse and Crime Prevention Act of 2000: What we need to know; what we’ve learned so far. Offender Substance Abuse Report, 2(2).

Publication profiles: 1. Pubmed: https://www.ncbi.nlm.nih.gov/myncbi/1-A8Ooz2e73Ql/bibliography/public/

2. Google Scholar:

https://scholar.google.com/citations?hl=en&user=8uVtYDcAAAAJ&view_op=list_works&sortby=pubdate

3. ResearchGate: https://www.researchgate.net/profile/Elizabeth_Evans14

https://www.ncbi.nlm.nih.gov/myncbi/1-A8Ooz2e73Ql/bibliography/public/



https://www.researchgate.net/profile/Elizabeth_Evans14


Page 9 of 29

Co-Edited Journal Issue

Friedmann, P., Evans, E., et al. (2020). Justice Community Opioid Innovation Network (JCOIN)

Protocols. Journal of Substance Abuse Treatment. In prep.

Book chapter

Evans, E., & Hser, YI. (2019). The natural history, clinical course, and long-term recovery from opioid use disorders. In Kelly and Wakeman (editors), Treating Opioid Addiction. Humana Press, Springer

International. DOI: 10.1007/978-3-030-16257-3_9.

Editorials (not peer-reviewed)

Friedmann, P., Abraham, A., Evans, E., Glass, J., Ilgen, M., Montgomery, L. (2020). Editorial: COVID-19

and its impact on SUD treatment. Journal of Substance Abuse Treatment. Vol 117, 108091. PMID: 32747147.

Montgomery, L., Friedmann, P., Abraham, A., Evans, E., Glass, J., Ilgen, M., (2020). Editorial: Health

equity in substance use disorder treatment. Journal of Substance Abuse Treatment. Vol 118, 108101. PMID: 32807568.

Evaluation reports, technical reports, monographs (not peer-reviewed) 1. Evans, E., Harrington, C., Delorme, E., Xu, J., Izidoro, I. (2020). The Medication Assisted Treatment

and Re-entry Initiative - Year 2 Report. Submitted to the Franklin County Sheriff’s Office.

SAMHSA, CSAT.

2. Bailey, A., Hano, S., Orakwue, K., Evans, E. (2020). Holyoke Early Access to Recovery (HEART) Program: Program Development and Plans for Implementation. Submitted to the Holyoke District

Court.

3. Evans, E., Harrington, C., Delorme, E., Cyr, K. (2019). The Medication Assisted Treatment and Re-entry Initiative - Year 1 Report. Submitted to the Franklin County Sheriff’s Office. SAMHSA,

CSAT.

4. Evans, E., Delorme, E., Harrington, C. (2019). The Massachusetts Public Health Data (PHD) Warehouse: Conceptual Framework for Action. Submitted to the Massachusetts Department of

Public Health (MDPH).

5. Evans, E., Delorme, E., Harrington, C. (2019). The Massachusetts Public Health Data (PHD)

Warehouse: History, Current Operation, and Impacts. Submitted to the Massachusetts Department of Public Health (MDPH).

6. Evans, E., Whitehill, J., Goldwater, E., Stanek, E., Brierley-Bowers, P., & Buchanan, D. (2018). “Task

1 Chapter 2: Prevalence and correlates of marijuana use among adults in Massachusetts, 2017.” In Marijuana Baseline Health Study. Submitted to the Massachusetts Department of Public Health.

7. Whitehill, J., Fitzpatrick, C., Goldwater, E., Evans, E., Stanek, E., Jette, T., Brierley-Bowers, P., &

Buchanan, D. (2018). “Task 2 Chapter 2: Driving under the influence of marijuana and marijuana-involved motor vehicle crashes in Massachusetts.” In Marijuana Baseline Health Study. Submitted

to the Massachusetts Department of Public Health.

8. Evans, E., Levin, D., Li, L., & Hser, Y.I. (2014). Long-term Effects of Specialized Treatment for Women with Substance Use Disorders. Counselor Magazine. August 2014, No. 4, p. 64-69.

9. Evans, E. (2014). Treating, Rather Than Incarcerating, Nonviolent Drug Offenders Saves Money.

UCLA ISAP News, 12 (1), 1. 10. Evans, E., Urada, D., & Fan, J. (2010). “Chapter 6: Criminal Justice Admissions: Characteristics and

Outcomes.” In Urada, D., et al., Criminal Justice Treatment Study Interim Report. Submitted to the California Department of Alcohol and Drug Programs.


Page 10 of 29

11. Evans, E., Hunter, J., & Urada, D. (2009). “Chapter 1: Characteristics of Proposition 36 Offenders.” In Urada, D., et al., Evaluation of the Substance Abuse and Crime Prevention Act 2009 Report.

Submitted to the California Department of Alcohol and Drug Programs.

12. Evans, E., Hunter, J., & Urada, D. (2009). “Chapter 2: Treatment Placement and Wait Time, Treatment

Completion and Non-Completion, Early Treatment Dropout, Treatment Outcome Indicators, and Treatment Re-entry.” In Urada, D., et al., Evaluation of the Substance Abuse and Crime Prevention

Act 2009 Report. Submitted to the California Department of Alcohol and Drug Programs.

13. Evans, E. (2009). “Chapter 10: Key Components of Proposition 36 Program Success: Lessons from Six High Performing Counties.” In Urada, D., et al., Evaluation of the Substance Abuse and Crime

Prevention Act 2009 Report. Submitted to the California Department of Alcohol and Drug

Programs. 14. Yang, J., Evans, E., Hunter, J., & Grella, C. (2009). “Chapter 3: Gender Differences among

Proposition 36 Clients.” In Urada, D., et al., Evaluation of the Substance Abuse and Crime

Prevention Act 2009 Report. Submitted to the California Department of Alcohol and Drug

Programs. 15. Evans, E. (2008). “Employment Assistance in Proposition 36” in Urada, D., et al., Evaluation of the

Substance Abuse and Crime Prevention Act 2008 Report. Submitted to the California Department

of Alcohol and Drug Programs. 16. Urada, D. Hawken, A., Conner, B., Evans, E., et al. (2008). Evaluation of the Substance Abuse and

Crime Prevention Act 2008 Report. Submitted to the California Department of Alcohol and Drug

Programs. 17. Urada, D. & Evans, E. (2008). ISAP Releases 2008 Report on Evaluation of California’s Proposition

36. UCLA ISAP News, 6 (1), 2.

18. Brecht, M.-L., Podus, D., Hamilton, A., Hall., E., Hardy, M., Teruya, C., Herbeck, D., Evans, E., &

Yang, J. (2006) Problem Gambling Prevention: Technical Assistance and Training Needs Assessment, Final Report. Submitted to the California Alcohol & Drug Program Office of Problem

Gambling.

19. Longshore, D., Urada, D., Evans, E., Hser, Y.-I., Prendergast, M., & Hawken, A. (2005). Evaluation of the Substance Abuse and Crime Prevention Act 2004 Report. Submitted to the California

Department of Alcohol and Drug Programs.

20. Hser, Y.-I., Grella, C., Evans, E., Huang, Y.C., & Spear, S. (2004). Treatment Outcomes and

Predictors for Special Populations in the California Treatment Outcome Project (CalTOP). Submitted to the California Department of Alcohol and Drug Programs.

21. Longshore, D., Urada, D., Evans, E., Hser, Y.-I., Prendergast, M., Hawken, A., Bunch, T., & Ettner, S.

(2004). Evaluation of the Substance Abuse and Crime Prevention Act 2003 Report. Submitted to the California Department of Alcohol and Drug Programs.

22. Hser, Y.-I., Evans, E., Ettner, S., Huang, D., Picazo, R. (2003). The California Treatment Outcome

Project Supplement to the Final Report. Submitted to the California Department of Alcohol and Drug Programs.

23. Longshore, D., Evans, E., Urada, D., Teruya, C., Hardy, M., Hser, Y.-I., Prendergast, M., & Ettner, S.

(2003). Evaluation of the Substance Abuse and Crime Prevention Act 2002 Report. Submitted to

the California Department of Alcohol and Drug Programs. 24. Hser, Y.-I., Evans, E., Teruya, C., Hardy, M., Ettner, S., Urada, D., Huang, Y., Picazo, R., Shen, H.,

Hsieh, J., Anglin, D. (2003). The California Treatment Outcome Project (CalTOP) Final Report.

Submitted to the California Department of Alcohol and Drug Programs. 25. Longshore, D., Hser, Y.-I., Prendergast, M., Ettner, S., Anglin, D., Evans, E. (2002). The Substance

Abuse and Crime Prevention Act Evaluation Year 1 Report. Submitted to the California Department

of Alcohol and Drug Programs. 26. Evans, E., & Hser, Y.-I. (2001). Client access to in-treatment services. NIDA Research Monograph

CPDD 2000, U.S. Government Printing Office.


Page 11 of 29

27. Evans, E., Allnutt, D., Curtis, C., & Pennell, S. (1994). Uniform Crime Report Quality Control Study. San Diego Association of Governments.

28. Pennell, S., Evans, E., Melton, R., & Hinson, S. (1994). Down for the Set: Describing and Defining

Gangs in San Diego. San Diego Association of Governments.

29. Pennell, S., Curtis, C., Hoctor, D., Melton, R., & Evans, E. (1994). Crime in the San Diego Region 1993 Annual Report. San Diego Association of Governments.

30. Pennell, S. & Evans, E. (1993). Drug Use Forecasting for Planning and Policymaking. San Diego

Association of Governments. 31. Draper, C. & Evans, E. (1992). San Diego Drug Use Forecasting Program Procedural Manual. San

Diego Association of Governments.

32. Pennell, S., Curtis, C., Hoctor, D., & Evans, E. (1992). Crime in the San Diego Region: 1992 Mid-Year Report. San Diego Association of Governments.

33. Pennell, S., Curtis, C., Hoctor, D., & Evans, E. (1990). Drug Abuse in San Diego County. San Diego

Association of Governments.

34. Pennell, S., Curtis, C., Hoctor, D., & Evans, E. (1990). Needs Assessment of Substance Abuse in San Diego County. San Diego Association of Governments.

PRESENTATIONS – SCIENTIFIC CONFERENCES

1. Evans, E., Delorme, E., Cyr, K. Using big data in ethical ways to address the opioid epidemic: Insights from data scientists, policymakers, and patient advocates. Oral presentation at the American Public

Health Association 2020 Annual Research Conference. October 27, 2020.

2. Shaffer, P., Delorme, E., Achuck, E., Cyr, K., Evans, E. Utility of Big Data for Research on the

Current Opioid Epidemic. Presentation at the American Public Health Association 2020 Annual Research Conference. October 27, 2020.

3. Delorme, E. Cyr, K., Evans, E. Community advisory boards as a key component of ethical big data

governance: Lessons learned from the opioid epidemic in Massachusetts. Oral presentation at the American Public Health Association 2020 Annual Research Conference. October 27, 2020.

4. Evans, E., Harrington, C., Cyr, K., Delorme, E. Challenges, facilitators, and benefits of delivering

medications to treat opioid use disorder in rural jail settings. Oral presentation at the American

Public Health Association 2020 Annual Research Conference. October 26, 2020. 5. Evans, E., Hayes, E., Cady, M., Hicks, S. A criminal justice-engaged research collaborative: Findings

and lessons learned from Western Massachusetts. Oral presentation at 9th Annual Community

Engagement and Research Symposium, UMass Medical School. October 14, 2020. 6. Evans, E. Recidivism after MOUD in Jail. Steering Committee Meeting, NIH Justice Community

Opioid Innovation Network (JCOIN). September 29, 2020.

7. Evans, E., Delorme, E., Cyr, K. Using big data in ethical ways to address the opioid epidemic: Insights from data scientists, policymakers, and patient advocates. Oral presentation IAB World Congress

of Bioethics June 2020.

8. Lemere, S., Harrington, C., Evans, E. How to Use Shared Decision-Making to Improve Patient Use of

Medications for Opioid Use Disorder (MOUD). College on Problems of Drug Dependence, 2020 Annual Scientific Meeting. Online. June 2020.

9. Harrington, C., Lemere, S., Evans, E. Appropriateness of using clinical directness to treat patients with

opioid use disorder. College on Problems of Drug Dependence, 2020 Annual Scientific Meeting. Online. June 2020.

10. Evans, E., Delorme, E., Cyr, K. Using big data in ethical ways to address the opioid epidemic: Insights

from data scientists, policymakers, and patient advocates. College on Problems of Drug Dependence, 2020 Annual Scientific Meeting. Online. June 2020.


Page 12 of 29

11. Evans, E., Harrington, C., Buchanan, B. Perceived benefits and harms of involuntary civil commitment for opioid use disorder. Accepted for oral presentation at the 13th Academic and Health Policy on

Conference on Correctional Health, April 2020. Event cancelled due to COVID-19.

12. Geissler, K., Evans, E., Johnson, J., Whitehill, J.M. Utility of Survey and Administrative Data for

Understanding Health Impacts of Policy Changes Related to Substance Use. Accepted for presentation at the American Public Health Association 2019 Annual Research Conference.

13. Evans, E., Harrington, C., Buchanan, B. Benefits and harms of involuntary civil commitment for opioid

use disorder. Oral presentation at the American Public Health Association 2019 Annual Research Conference. November 2, 2019, Philadelphia, PA.

14. Fiddian-Green, A., Gubrium, A., & Evans, E. Women-reported barriers and facilitators of adherence

to medications for opioid use disorder. Poster presentation at the American Public Health Association 2019 Annual Research Conference. November 2, 2019, Philadelphia, PA.

15. Hamilton, A., Pedersen, Cohen, A., Evans, E., Young, A. The Effect of Gender on the Functioning and

Recovery of Patients with Schizophrenia. Presentation at Academy Health 2019 Annual meeting.

16. Geissler, K., Evans, E., Whitehill, J.M. Utility of Epidemiological and Administrative Data for Understanding Health Impacts of Policy Changes Related to Substance Use. Presentation at

Academy Health 2019 Annual meeting.

17. Fiddian-Green, A., Gubrium, A., & Evans, E. Women-reported barriers and facilitators of adherence to medications for opioid use disorder. Poster presented at InWomen’s Annual Meeting. San

Antonio, TX. June 2019.

18. Geissler, K., Evans, E., Johnson, J., Whitehill, J.M. Utility of Survey and Administrative Data for Understanding Health Impacts of Policy Changes Related to Substance Use. Presented at the

American Society of Health Economists 2019 Annual Research Conference. Washington DC, June

23-26, 2019.

19. Evans., E., Zhu, Y., Yoo, C., Hser, YI. Arrests over 5 years among adults treated with buprenorphine-naloxone or methadone for opioid use disorder. Poster presented at College on Problems of Drug

Dependence, 2019 Annual Scientific Meeting, San Antonio, TX. June 2019.

20. Fiddian-Green, A. & Evans, E. Barriers and Facilitators of Women’s Adherence to Medications for Opioid Use Disorder. Poster presented at College on Problems of Drug Dependence, 2019 Annual

Scientific Meeting, San Antonio, TX. June 2019.

21. Fiddian-Green, A., Gubrium, A., & Evans, E. Women-reported barriers and facilitators of adherence

to medications for opioid use disorder. Poster presented at UMCCTS 8th Annual Community Engagement and Research Symposium. Worcester, MA. March 22, 2019.

22. Evans., E. & Taylor, S. Gender Disparities in the Use of Complementary and Integrative Health by

U.S. Military Veterans w/ Chronic Musculoskeletal Pain. VA HSR&D Cyberseminar – Focus on Women’s Health. November 29, 2018.

23. Evans., E. & Grella, C. Gender differences in associations between childhood adversity and mental

health comorbidity among adults with opioid use disorders: Results from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III). Oral presentation at the

American Public Health Association 2018 Annual Research Conference, San Diego, CA.

November 2018.

24. Evans., E., Herman, P., Washington, D., Lorez, K.A., Yuan, A., Upchurch, D.M., Marshall, N., Hamilton, A.B., & Taylor, S.L. Gender differences in use of complementary and integrative health

by U.S. military veterans with chronic musculoskeletal pain. Poster presentation at the American

Public Health Association 2018 Annual Research Conference, San Diego, CA. November 13, 2018.

25. Evans., E., Yoo, C., Huang, D., Saxon, A.J., Hser, YI. Effects of access barriers and acceptability on

buprenorphine-naloxone treatment utilization over 5 years: Results from a multisite randomized trial. Poster presentation at the American Public Health Association 2018 Annual Research

Conference, San Diego, CA. November 2018.


Page 13 of 29

26. Whitehill, J.M., Evans, E., Goldwater, E., & Buchanan, D. Substance use and impaired driving after marijuana legalization in Massachusetts: Results from a statewide survey of adults. Oral

presentation at the American Public Health Association 2018 Annual Research Conference, San

Diego, CA. November 2018.

27. Evans., E. & Grella, C. Gender differences in associations between childhood adversity and mental health comorbidity among adults with opioid use disorders: Results from the 2012-2013 National

Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III). Oral presentation at

College on Problems of Drug Dependence, 2018 Annual Scientific Meeting, San Diego, CA. June 2018.

28. Evans, E., Glover, D., Washington, D., & Hamilton, A. Factors that shape the health of women

veterans treated in community-based settings. Oral presentation for session titled: “The Body Politic: Mental and Physical Health of Female Veterans and the VA,” American Anthropological

Association (AAA) Annual Research Conference, Washington, DC. November 29, 2017.

29. Krebs, E., Enns, B., Evans, E., Urada, D., Anglin, M.D., Rawson, R.A., Hser, Y.I. Cost effectiveness of

evidence-based practice in California’s publicly funded treatment of opioid use disorders. Oral presentation at the American Public Health Association 2017 Annual Research Conference,

Atlanta, GA. November 8, 2017.

30. Evans, E., Grella, C., Washington, D., & Upchurch, D. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Poster presented at College on

Problems of Drug Dependence, 2017 Annual Scientific Meeting, Montreal, Canada.

31. Evans, E., Upchurch, D., Simpson, T., Hamilton, A., Hoggatt, K. Gender differences among US veteran and civilian populations in experiences of childhood adversity and occurrence of alcohol,

drug, and poly-substance use disorders. Poster presented at Biennial UCLA CALDAR Summer

Institute Research Conference, August 16, 2017.

32. Evans, E., Glover, D., Washington, D., & Hamilton, A. How the Veterans Administration can increase healthcare access and utilization of needed care by improving the safety, quality, and value of

services for women Veterans. Poster presented at Academy Health 2017 Annual Research

Conference, New Orleans, LA. 33. Evans, E., Grella, C., Washington, D., & Upchurch, D. Gender and race/ethnic differences in the

persistence of alcohol, drug, and poly-substance use disorders. Poster presented at Academy Health

2017 Annual Research Conference, New Orleans, LA.

34. Evans E., Upchurch D., Grella C. Gender differences in the effect of childhood adversity on alcohol, drug, and poly-substance use disorders. Poster presented at Academy Health 2017 Annual

Research Conference, New Orleans, LA.

35. Evans E. Mining nationally representative data to understand gender and race/ethnic differences in the occurrence and persistence of alcohol, drug, and poly-substance use disorders: Findings and

future directions. Webinar presentation at the Veterans Affairs (VA) Women’s Health Research

Network (WHRN) Substance Use Disorders (SUD) Workgroup. January 17, 2017. 36. Evans E., Upchurch D., Grella C. Gender differences in the effect of childhood adversity on alcohol,

drug, and poly-substance use disorders. Paper presented at the College on Problems of Drug

Dependence, 2016 Annual Scientific Meeting, Palm Springs, CA.

37. Krebs E., Huang D., Evans E., Urada D., Hser YI., Nosyk B. The effect of treatment for opioid use disorders on the costs of crime. Paper presented at the College on Problems of Drug Dependence,

2016 Annual Scientific Meeting, Palm Springs, CA.

38. Evans E. Using Electronic Health Records (EHR) to examine co-occurring conditions, health services utilization, and outcomes among patients in primary care settings who use marijuana. Oral

presentation at the UCLA Integrative Center on Addictions Seminar. November 5, 2015. UCLA

Semel Institute. 39. Krebs E, Min JE, Li L, Evans E, Rawson RA, Hser YI, Nosyk B. Modeling the cost-effectiveness of

opioid agonist treatment policy alternatives in California’s publicly-funded drug treatment


Page 14 of 29

facilities. Presented at the 37th Annual Meeting of the Society for Medical Decision Making. October 18-21, 2015, St. Louis, MO.

40. Evans E, Upchurch, D., Grella, C. Gender differences in the effect of childhood adversity on the

occurrence of different types of substance use disorders. Poster presented at the Addiction Health

Services Research, Annual Scientific Meeting, October 14-16, 2015, Los Angeles, CA. 41. Evans E, Li L, Min J, Huang D, Urada D, Hser YI, Nosyk B. Mortality among women and men

accessing pharmacological treatment for opioid dependence in California, 2006 – 2010. Poster

presented at the American Psychological Association, Annual Scientific Meeting, August 6-9, 2015, Toronto.

42. Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD , Wood E, Montaner JSG. The effects of opioid

substitution treatment and highly active antiretroviral therapy on the cause-specific risk of mortality among injection drug using people living with HIV/AIDS. Paper presented at the 8th IAS

Conference on HIV Pathogenesis, Treatment and Prevention; July 20, 2015, Vancouver, BC.

43. Evans E, Li L, Min J, Huang D, Urada D, Hser YI, Nosyk B. Mortality among women and men

accessing pharmacological treatment for opioid dependence in California, 2006 – 2010. Poster presented at the College on Problems of Drug Dependence, 2015 Annual Scientific Meeting,

Phoenix, AZ.

44. Krebs E, Li L, Min JE, Evans E, …, Nosyk B. The cost-effectiveness of opioid agonist treatment (OAT) in California’s publicly-funded drug treatment facilities. Poster presented at the College on

Problems of Drug Dependence, 2015 Annual Scientific Meeting, Phoenix, AZ.

45. Li L, Evans E, Min J, Liu L, Huang D, Urada D, Wood E, Hser YI, Nosyk B. Health state transitions among prescribed opiate patients accessing pharmacological treatment for opioid dependence in

California, 2006 – 2010. Poster presented at the College on Problems of Drug Dependence, 2015

Annual Scientific Meeting, Phoenix, AZ.

46. Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD , Wood E, Montaner JSG. The effects of opioid substitution treatment and highly active antiretroviral therapy on the cause-specific risk of

mortality among injection drug using people living with HIV/AIDS. Paper presented at the College

on Problems of Drug Dependence, 2015 Annual Scientific Meeting, Phoenix, AZ. 47. Evans, E., Li, L., Min, J., Huang, D., Urada, D., Hser, Y.I., & Nosyk, B. Mortality among women and

men treated for opioid dependence. Poster presented at the Biennial Meeting of the International

Conference on Global Health: Prevention and Treatment of Substance Abuse and HIV, April 22-24,

2015, Hangzhou, China. 48. Evans E, Nosyk B, Li L, Huang D, Brecht ML, Hser YI. Determinants of mortality among publicly-

funded opioid substitution treatment clients in California, USA: 2006-2010. Poster presented at

College on Problems of Drug Dependence, 2014 Annual Scientific Meeting, Puerto Rico. 49. Nosyk, B., et al. The causal effect of opioid substitution treatment on highly active antiretroviral

treatment adherence. College on Problems of Drug Dependence, 2014 Annual Scientific Meeting,

Puerto Rico. 50. Evans, E., Li, L., Lin, V., Hser, YI. Factors associated with differential use of mental health services

among women over 8 years after substance abuse treatment. Poster presented at College on

Problems of Drug Dependence, 2014 Annual Scientific Meeting, Puerto Rico.

51. Nosyk, B., Evans, E., Li, L., Urada, D., Milloy, M.J., Wood, E., Rawson, R., & Hser, Y.I. Opioid substitution treatment enrollment and outcomes in California: 1991-2011. Poster presented at

College on Problems of Drug Dependence, 2013 Annual Scientific Meeting, San Diego, CA.

52. Li, L., Nosyk, B., Evans, E., Huang, D., Min, J., Kerr, T., Brecht, M.L., & Hser, Y.I. Changes in drug use frequency as a recurrent event process: Analyses on the natural history of drug abuse. Poster

presented at College on Problems of Drug Dependence, 2013 Annual Scientific Meeting, San

Diego, CA. 53. Evans, E., Nosyk, B., Li, L., Urada, D., Milloy, M.J., Wood, E., Rawson, R., & Hser, Y.I. Opioid

substitution treatment enrollment and outcomes in California: 1991-2011. Poster presented at the


Page 15 of 29

International Conference on Global Health: Prevention and Treatment of Substance Abuse and HIV, Taipei, Taiwan, April 17-18, 2013.

54. Evans, E., Li, L., Grella, C., Brecht, M.L., & Hser, Y.I. Developmental timing of first drug treatment

and 10-year patterns of drug use. Poster presented at Addiction Health Services Research Meeting,

New York, October 17-19, 2012. 55. Evans, E., Li, L., Grella, C., Brecht, M.L., & Hser, Y.I. Developmental timing of first drug treatment

and 10-year patterns of drug use. Oral presentation at American Public Health Association, San

Francisco, October 31, 2012. 56. Evans, E., Huang, D., & Hser, Y.I. Predictors of stable drug use recovery over 30 years. Oral

presentation at Addiction Health Services Research Meeting, New York, October 17-19, 2012.

57. Evans, E., Hser, Y., Du, J., Li, J., Zhao, M., Chang, Y.J., & Peng, C.Y. Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. Poster presented at UC Global

Health Day, Berkeley, California, February 4, 2012.

58. Evans, E., Li, L., Hunt, S., & Hser, Y.I. Perceived neighborhood safety, social capital, and drug use abstinence among mothers 10 years after substance abuse treatment. Poster presented at College on

Problems of Drug Dependence, 2012 Annual Scientific Meeting, Palm Springs, CA, June 9 - 14,

2012. 59. Du, J., Lombardi, C., Evans, E., Zhao, M., Meng, Y.Y. A mixed methods approach to identifying

factors related to voluntary HIV testing among injection drug users in Shanghai, China. Poster

presented at College on Problems of Drug Dependence, 2012 Annual Scientific Meeting, Palm Springs, CA, June 9 - 14, 2012.

60. Li, L., Evans, E., Metchik, A., & Hser, Y.I. Long-term outcomes among drug dependent mothers.

Poster presented at College on Problems of Drug Dependence, 2012 Annual Scientific Meeting, Palm Springs, CA, June 9 - 14, 2012.

61. Hser, Y.I., Evans, E., Li, L., Metchik, A., & Messina, N. Maternal substance abuse and child

behavior: a 10-year prospective study. Poster presented at College on Problems of Drug Dependence, 2012 Annual Scientific Meeting, Palm Springs, CA, June 9 - 14, 2012.

62. Hser, Y.H., Kagihara, J., Huang, D., Messina, N., & Evans, E. Mortality among substance-using

mothers in California: a 10-year prospective study. Poster presented at American Public Health Association 139th Annual Meeting and Exposition, Washington DC, October 29 - November 2,

2011.

63. Hser, Y., Evans, E., Huang, D., Li, L., Metchik, A., & Messina, N. Children of treated substance-abusing mothers. Poster presented at College on Problems of Drug Dependence, Annual Scientific

Meeting, Hollywood, Florida, June 20, 2011.

64. Nosyk, B., Evans, E., Sun, H., Anglin, M.D., & Anis, A.H. A population-level study of methadone maintenance treatment withdrawal patterns: what is predictive of success? Poster presented at

College on Problems of Drug Dependence, Annual Scientific Meeting, Hollywood, Florida, June

20, 2011. 65. Evans, E., Li, L., Brecht, M.L., & Hser, Y.I. Drug use relapse after first treatment among emerging

adults. Poster presented at College on Problems of Drug Dependence, Annual Scientific Meeting,

Hollywood, Florida, June 20, 2011. 66. Hser, Y., Messina, N., Evans, E., Huang, D. A Long-term Follow-up Study of Drug Dependent Mothers

and Their Children: Early Analyses and Preliminary Results. Poster presented at American Society

of Criminology, San Francisco, California, November 19, 2010.

67. Evans, E., Chang, Y., Huang, D., & Hser, Y.I. Receipt of continuing care by parenting women. Poster presented at College on Problems of Drug Dependence, Annual Scientific Meeting, Scottsdale,

Arizona, June 12-17, 2010.

68. Hser et al., Gender Differences in HIV Risk Behaviors and Other issues among Chinese Methadone Patients. Poster presented at NIDA International Forum, Annual Scientific Meeting, Scottsdale,

Arizona, June 11-15, 2010.


Page 16 of 29

69. Hser et al., Contingency Management for Chinese Methadone Patients. Poster presented at NIDA International Forum, Annual Scientific Meeting, Scottsdale, Arizona, June 11-15, 2010.

70. Hser, Y.I., Chang, Y., Evans, E., & Messina, N. Hispanic parenting women in women-only versus

mixed-gender drug treatment. Poster presented at College on Problems of Drug Dependence,

Annual Scientific Meeting, Scottsdale, Arizona, June 12-17, 2010. 71. Evans, E., Li, L., & Urada, D. Variation in outcomes of two of California’s criminal justice-supervised

drug treatment models: Proposition 36 and drug court. Poster presented at Addiction Health

Services Research Conference, San Francisco, CA, October 28 – 30, 2009. 72. Hser, Y.-I., Evans, E., Chang, Y.J., Huang, D., & Messina, N. A long-term follow-up of drug

dependent mothers and their children: Early analyses and preliminary results. Poster presented at

Addiction Health Services Research Conference, San Francisco, CA, October 28 – 30, 2009. 73. Evans, E. & Hser, Y.-I. Promising practices for an employment-improvement intervention for criminal

justice populations in drug treatment settings. Poster presented at Addiction Health Services

Research Conference, San Francisco, CA, October 28 – 30, 2009.

74. Evans, E., Jaffe, A., & Urada, D. Enhancing outcomes for parolees in court-supervised substance abuse treatment. Poster presented at Addiction Health Services Research Conference, San

Francisco, CA, October 28 – 30, 2009.

75. Yang, J.C., Li, L., Evans, E., Hunter, J., & Grella, C. Women in Proposition 36 treatment by dependent children status. Poster presented at Addiction Health Services Research Conference,

San Francisco, CA, October 28 – 30, 2009.

76. Evans, E. Collaborative justice courts and California’s Proposition 36 drug diversion initiative. Oral presentation at NIDA Summer Internship Speaker Series. Los Angeles, CA, July 21, 2009.

77. Evans, E., Li, L., Marinelli-Casey, P., Rawson, R, & Hser, Y.-I. Service needs, treatment utilization,

and outcomes of Asian Americans in drug treatment. Poster presented at College on Problems of

Drug Dependence, Annual Scientific Meeting, Reno, Nevada, June 22-25, 2009. 78. Li, L., Evans, E., & Hser, Y.-I. A marginal structure modeling approach for assessing the cumulative

effect of drug treatment. Poster presented at College on Problems of Drug Dependence, Annual

Scientific Meeting, Reno, Nevada, June 22-25, 2009. 79. Urada, D., Evans, E., Yang, J., Fan, J., Conner, B., Anglin, M.D., Rawson, R., Rutkowski, B., Hunter,

J., Hawken, A., Teruya, C., Gonzales, R., Campos, M., & Brecht, M.L. Evaluation of criminal

justice diversion: California’s Proposition 36. Poster presented at College on Problems of Drug

Dependence, Annual Scientific Meeting, Reno, Nevada, June 22-25, 2009. 80. Evans, E. & Urada, D. Employment assistance for California’s Proposition 36 drug offenders. Poster

presented at Addiction Health Services Research. Boston, Massachusetts, October 20-22, 2008.

81. Evans, E., Huang, D., & Hser, Y.-I. High-risk offenders in California’s Proposition 36. Poster presented at College on Problems of Drug Dependence, Annual Scientific Meeting, San Juan,

Puerto Rico, June 14-19, 2008.

82. Urada, D., Evans, E., Hawken, A., Conner, B.T., & Longshore, D. Evaluation of California's Proposition 36: An initiative offering treatment to non-violent drug offenders. Poster presented at

College on Problems of Drug Dependence, Annual Scientific Meeting, San Juan, Puerto Rico, June

14-19, 2008.

83. Brecht, M.-L., Huang, D., Evans, E., & Hser, Y.-I. Polydrug use and implications for longitudinal research: Ten-year trajectories for heroin, cocaine, and methamphetamine users. Poster presented

at College on Problems of Drug Dependence, Annual Scientific Meeting, San Juan, Puerto Rico,

June 14-19, 2008. 84. Murphy, D., Brecht, M., Herbeck, D., Evans, E., Li, L., & Hillhouse, M. Longitudinal trajectories of

HIV risk behaviors among methamphetamine users. Poster presented at College on Problems of

Drug Dependence, Annual Scientific Meeting, San Juan, Puerto Rico, June 14-19, 2008. 85. Hser, Y.-I. & Evans, E. High-risk offenders in California's Proposition 36. Poster presented at College

on Problems of Drug Dependence, Annual Scientific Meeting, San Juan, Puerto Rico, June 14-19,

2008.


Page 17 of 29

86. Evans, E., Li, L., & Hser, Y.-I. Treatment entry barriers identified by California’s Proposition 36 offenders: Characteristics, perceptions, and re-arrest rates of untreated and treated offenders.

Poster presented at Addiction Health Services Research. Athens, Georgia, October 15-17, 2007.

87. Brecht, M.-L. & Evans, E. Problem gambling prevention: Needs assessment for technical

assistance/training among service providers. Oral presentation at California Problem Gambling Prevention Statewide Summit. Sacramento, March 8, 2007.

88. Brecht, M.-L. & Evans, E. HIV risk behaviors and intention to change among heterosexual

methamphetamine-using offenders in drug treatment. Poster presented at College on Problems of Drug Dependence, Annual Scientific Meeting, June 2007.

89. Evans, E. & Brecht, M.-L (2007) Need for technical assistance and training on problem gambling

among substance use treatment and other social/health service providers. Poster presented at College on Problems of Drug Dependence, Annual Scientific Meeting, June 2007.

90. Evans, E., Brecht, M.-L., & Warda, U. HIV prevention for heterosexual meth users in drug treatment.

Oral presentation at Addiction Health Services Research. Little Rock, Arkansas, October 25, 2006.

91. Evans, E., Fan, J. & Hser, Y.-I. Characteristics of overweight long-term narcotic users. Poster presented at UCLA Summer Institute on Longitudinal Research. Los Angeles, August 14, 2006.

92. Evans, E., Fan, J. & Hser, Y.-I. Characteristics of overweight long-term narcotic users. Poster

presented at College on Problems of Drug Dependence, Annual Scientific Meeting, Scottsdale, Arizona, June 17-22, 2006.

93. Hser, Y.-I., Evans, E., & Huang, D. Treatment motivation, completion, and short-term outcomes of

Proposition 36 in five California counties. Oral presentation at American Society of Criminology Annual Meeting, Toronto, Canada, November 15 – 19, 2005.

94. Hser, Y.-I., Evans, E., Huang, D., & Fan. J. Short-term outcomes of Proposition 36 in five California

counties. Poster presented at College on Problems of Drug Dependence, 67th Annual Scientific

Meeting, Orlando, Florida, June 18 - 23, 2005. 95. Evans, E., Spear, S., Huang, D., & Hser, Y.-I. Treatment outcomes among American Indians in

California. Poster presented at College on Problems of Drug Dependence, 67th Annual Scientific

Meeting, Orlando, Florida, June 18 - 23, 2005. 96. Evans, E. Tips for improving survey response: Instrument design and administration wisdom from Dr.

Don Dillman. Oral presentation at UCLA ISAP Scientific Meeting, Los Angeles, CA, May 20,

2005.

97. Evans, E., Teruya, C., Hser, Y.-I., & Fan, J. Treatment capacity and gender differences among Prop 36 clients. Oral presentation at Riverside County Proposition 36 Quarterly Treatment Provider

Meeting, March 16, 2005.

98. Longshore, D., Evans, E., & Hardy, M. Findings from the statewide evaluation and treatment system impact study. Oral presentation at Kern County Mental Health Substance Abuse System of Care

Summer Institute Training, August 24, 2004.

99. Evans, E., Hser, Y.-I., & Huang, D. Long-term patterns of criminal activities among cocaine-dependent users and effect of treatment. Poster presented at College on Problems of Drug

Dependence, 66th Annual Scientific Meeting, San Juan, Puerto Rico, June 12-17, 2004.

100. Hser, Y.-I., Evans, E., & Grella, C. Drug treatment services, retention, and outcomes. Poster

presented at College on Problems of Drug Dependence, 66th Annual Scientific Meeting, San Juan, Puerto Rico, June 12-17, 2004.

101. Hardy, M., Teruya, C., Yang, J.C., Evans, E., Grella, C.E., & Hser, Y.-I. County strategies designed to

engage and retain clients in California’s Substance Abuse and Crime Prevention Act program (Proposition 36). Poster presented at College on Problems of Drug Dependence, 66th Annual

Scientific Meeting, San Juan, Puerto Rico, June 12-17, 2004.

102. Teruya, C., Hardy, M., Yang, J.C., Hser, Y.-I., & Evans, E. Impact of Proposition 36 on local treatment systems and their linkages to the criminal justice system: Perspectives of county

stakeholders. Poster presented at College on Problems of Drug Dependence, 66th Annual Scientific

Meeting, San Juan, Puerto Rico, June 12-17, 2004.


Page 18 of 29

103. Hser, Y.-I., Grella, C., Farabee, D., Teruya, C., & Evans, E. Impact of Proposition 36 on the treatment system. Poster presented at Case Media Fellowship, Los Angeles, CA, April 20, 2004.

104. Longshore, D., Evans, E., & Urada, D. Evaluation of the Substance Abuse and Crime Prevention Act.

Oral presentation at Making It Work Meeting, San Diego, CA, February 2004.

105. Longshore, D., Hser, Y.-I., Prendergast, M., & Evans, E. The Prop 36 “Pipeline.” Oral panel presentation at the 55th Annual Meeting of the American Society of Criminology, Denver, CO,

November 19, 2003.

106. Longshore, D., Evans, E., & Urada, D. Status of the Evaluation of the Substance Abuse and Crime Prevention Act. Oral presentation at County Lead Agency Implementation Meeting, Sacramento,

CA, October 28, 2003.

107. Hser, Y.-I., Evans, E., & Grella, C. Drug treatment services, retention, and outcomes: Findings from the California Treatment Outcome Project. Poster presented at the Health Services Research in

Substance Abuse Conference, Atlanta, Georgia, October 23, 2003.

108. Evans, E., & Hser, Y.-I. Findings from the California Treatment Outcome Project. Poster presented at

the College on Problems of Drug Dependence, 65th Annual Scientific Meeting, Bal Harbour, Florida, June 14-19, 2003.

109. Hser, Y.-I., Stark, E., Paredes, A., Anglin, D., Rawson, R., Boles, S., & Evans, E. A 12-Year follow-up

of a cocaine dependent sample: Preliminary findings. Poster presented at the College on Problems of Drug Dependence, 65th Annual Scientific Meeting, Bal Harbour, Florida, June 14-19, 2003.

110. Evans, E., & Hser, Y.-I. Findings from the California Treatment Outcome Project. Oral presentation at

Substance Abuse Research Consortium, Sacramento, CA, May 2003. 111. Longshore, D., Evans, E., Teruya, C., & Urada, D. Evaluation of the Substance Abuse and Crime

Prevention Act. Oral presentation at Making It Work Meeting, San Diego, CA, February 2003.

112. Longshore, D., Hser, Y.-I., Prendergast, M., Evans, E., & Anglin, D. The statewide Proposition 36

evaluation: Goals, design, and early findings. Oral panel presentation at the American Society of Criminology Conference, Chicago, IL, November 14, 2002.

113. Evans, E. & Hser, Y.-I. California Treatment Outcome Project: Preliminary findings on treatment

outcomes. Poster presented at the TOPPS II Final Steering Committee Meeting, Bethesda, MD, September 23, 2002.

114. Hser, Y.-I. & Evans, E. California Treatment Outcome Project: Preliminary results of final report.

Oral presentation to the TOPPS II Final Steering Committee Meeting, Bethesda, MD, September

23, 2002. 115. Evans, E., & Hser, Y.-I. Impact of Proposition 36 on patient services in California: Preliminary

results. Poster presented at the College on Problems of Drug Dependence, 64th Annual Scientific

Meeting, Quebec City, Canada, June 8-13, 2002. 116. Evans, E., & Hser, Y.-I. Patients’ needs, services and treatment satisfaction. Poster presented at the

College on Problems of Drug Dependence, 62nd Annual Scientific Meeting, San Juan, Puerto Rico,

June 17-22, 2000. 117. Evans, E., & Anglin, D.A. Update on the State Treatment Needs Assessment Project. Oral

presentation at Substance Abuse Research Consortium, Sacramento, CA, October 1999.

118. Curtis, C., Hoctor, D., Pennell, S., & Evans, E. Intensive supervision for drug-involved probationers: a

new approach. Paper presented to American Society of Criminology Annual Meeting, San Francisco, CA, November 20, 1991.

GRANTS AND CONTRACTS - PAST

I was the Project Director at UCLA on this $25 million portfolio of evaluation and research projects from

1999 to 2016.

1. The START Follow-up Study - Clinical Trials Network Protocol 0050. National Institute on Drug Abuse. Grant # U10 DA013045. PI: Hser. 09/10 – 05/16. Total amount: $2,500,000.


Page 19 of 29

2. Center for Advancing Longitudinal Drug Abuse Research (CALDAR). National Institute on Drug Abuse. Grant # P30 DA016383. PI: Hser. 09/10 – 08/15. Total amount: $4,394,840.

3. Conference Series To Promote Global Health: Training And Education In The Prevention And

Treatment Of Substance Use Disorders And HIV In Asian/Pacific Island Populations. National Institute

on Drug Abuse. Grant # R13 DA035084. PI: Hser. 12/12 – 11/17. Total amount: $250,000. 4. CALDAR Institute on Longitudinal Research Findings and Methods. National Institute on Drug

Abuse. Grant # R13 DA035084. PI: Hser. 01/14 - 12/19. Total amount: $75,000.

5. An Empirical Investigation into Recovery from Illicit Drug Abuse Using Recurrent Event Analysis. National Institute on Drug Abuse. Grant # R01 DA032551. PI: Montaner and Nosyk. 07/12 – 06/15.

Total amount: $506,504.

6. Neurocognitive Mechanisms and Recovery from Addiction. National Institute on Drug Abuse. Grant # R03 DA032542. PI: Hser. 06/12 – 07/14. Total amount: $221,463.

7. A Comparison of Health and Economic Outcomes of Methadone Maintenance Treatment Systems in

California, USA and British Columbia, Canada. National Institute on Drug Abuse. Grant # R01

DA031727. PI: Nosyk. 06/11 - 05/14. Total amount: $450,000. 8. Real-Time Assessment of Triggers and Coping Responses in China. National Institute on Drug Abuse.

Grant #R21 DA033285. PI: Hser. 07/12 - 08/14. Total amount: $334,867.

9. Drugged Driving: Future Research Directions. National Institute on Drug Abuse. SBIR Phase I Subcontract # N43 DA125572. PI: Farabee. 07/12 – 01/13. Total amount: $46,728.

10. CALDAR Institute on Longitudinal Research Findings and Methods. National Institute on Drug

Abuse. Grant # R13 DA024494. PI: Hser. 01/08 - 12/12. Total amount: $74,630. 11. A Long-term Follow-up of Drug Dependent Mothers and Their Children. National Institute on Drug

Abuse. Grant # R01 DA021183 PI: Hser. 06/09 – 06/11. Total amount: $570,000.

12. Improving Methadone Maintenance Treatment Compliance and Outcomes in China. National Institute

on Drug Abuse. Grant # R21 DA025252. PI: Hser. 08/08 – 07/10. Total amount: $275,000. No cost extension through 2011.

13. Reducing HIV/AIDS and Drug Abuse among Heroin Addicts Released from Compulsory

Rehabilitation in China. National Institute on Drug Abuse. Grant #: R21 DA025385. PI: Hser. 07/08 – 06/10. Total amount: $100,000. No cost extension through 2011.

14. Continuation of the Evaluation of the Substance Abuse Crime Prevention Act (SACPA III; Proposition

36). California Department of Alcohol and Drug Programs. PI: Urada. 12/07 – 12/10. Total amount:

$545,454. 15. Center for Advancing Longitudinal Drug Abuse Research (CALDAR). National Institute on Drug

Abuse. Grant # P30 DA016383. PI: Hser. 09/05 – 09/10. Total amount: $4,308,051 plus diversity

supplement $50,000. 16. Research on Racial and Ethnic Disparities in Access to Mental Health Care and Addiction-Related

Outcomes among Clients of Public Sector Substance Abuse Treatment Programs in California.

National Institute on Drug Abuse. Grant # R03 DA018762. PI: Heslin. 11/08 - 08/09. Total amount: $61,740.

17. Summer Research with NIDA: Mentoring the Next Generation of Drug Abuse Researchers. National

Institute on Drug Abuse. PI: Hser. 06/09 - 08/09. Total amount: $10,000.

18. Employment and Social Reintegration. UCLA Senate COR Program and UCLA Center for Community Partnerships. UCLA 2008/2009 COR-CCP Faculty Research Grants. PI: Hser. 07/08 – 06/09. Total

amount: $20,000.

19. Health Disparities among Native American/Alaska Native (NA/AN) and Asian American/Pacific Islander (AAPI) Populations; Differential Patterns of Drug Abuse, Services Utilization, and Treatment

Outcomes. National Institute on Drug Abuse. PI: Hser. 09/07 – 08/08.

20. Swiftness and Certainty in Enforcing Probation Conditions: Hawaii’s HOPE Program. Smith Richardson Foundation and National Institute of Justice. PI: Hawken and Kleiman. 08/07 – 08/08.

21. Treatment System Impact and Outcomes of Proposition 36 (TSI). National Institute on Drug Abuse.

Grant # R01DA15431. PI: Hser. 10/02 – 06/08. Total amount: $3,407,920.


Page 20 of 29

22. Continuation of the Evaluation of the Substance Abuse Crime Prevention Act (SACPA II). California Department of Alcohol and Drug Programs. PI: Urada. 12/06 – 12/07. Total amount: $600,000.

23. HIV Prevention for Heterosexual Methamphetamine Users in Drug Treatment. Universitywide AIDS

Research Program. PI: Brecht. 09/05 – 09/07. Total amount: $99,517.

24. Evaluation of the Substance Abuse Crime Prevention Act (SACPA I). California Department of Alcohol and Drug Programs. PI: Longshore. 12/01 – 12/06. Total amount: $3,500,000.

25. Needs Assessment for Problem Gambling Prevention Technical Assistance and Training. National

Asian Pacific American Families Against Substance Abuse, Inc. PI: Brecht. 05/06 – 08/06. Total amount: $336,093.

26. Drug Treatment and Mental Health Services: Access and Outcomes. Robert Wood Johnson

Foundation. Grant #052784. PI: Hser. 06/04 - 07/05. Total amount: $99,296. 27. Readiness for Implementation of Research to Practice (PARC). National Institute on Drug Abuse.

Grant # R01 DA014472. PI: Hser. 03/03 – 03/05. Total amount: $631,880.

28. A 12-Year Follow-up of a Cocaine Dependent Sample (CTE). National Institute on Drug Abuse. Grant

# R01 DA13594. PI: Hser. 04/03 – 04/04. Total amount: $1,694,115. 29. Cost Analysis and Operations Assessment of Community-based Alcohol and Drug Treatment

Programs. Robert Wood Johnson Foundation. Grant #046113. PI: Hser. 06/02 – 08/03. Total amount:

$99,147. 30. Extension of the California Treatment Outcome Project (CalTOP). California Department of Alcohol

and Drug Programs. PI: Hser. 06/02 – 08/03.

31. California Treatment Outcome Project (CalTOP). Center for Substance Abuse Treatment. Grant # TI-98-005. PI: Hser. 08/99 – 10/02. Total amount: $1,898,861.

32. State Treatment Needs Assessment Project (STNAP). Center for Substance Abuse Treatment. Grant #

270-98-7052. PI: Anglin. 08/99 – 08/00. Total amount: $1,478,345.

33. Substance Abuse Research Consortium (SARC). California Department of Alcohol and Drug Programs. PI: Anglin. 08/99 – 08/00.

TEACHING - COURSES

Spring

2020, Fall

2020

PUBHLTH 396-07 Independent Study: Community-based mixed methods research

Department of Health Sciences and Health Promotion, University of Massachusetts Amherst

Role: Professor

Undergraduate level – 4-5 students

Fall 2019,

Fall 2020

HPP 396/696/896 Independent study: Community-based mixed methods research

Department of Health Sciences and Health Promotion, University of Massachusetts Amherst Role: Professor

Undergraduate level – 7 students

Fall 2019, Fall 2018

HPP 603 Group dynamics Department of Health Sciences and Health Promotion, University of Massachusetts Amherst

Role: Professor

Graduate level – 30 students

Fall 2019,

Fall 2020

HPP 892D Doctoral seminar

Department of Health Sciences and Health Promotion, University of Massachusetts Amherst Role: Professor

Graduate level – 3-8 students

Spring 2018

HPP 590W Public health and literature Department of Health Sciences and Health Promotion, University of Massachusetts Amherst

Role: Professor


Page 21 of 29

Graduate level – 10 students

Spring

2020), Fall

2017

HPP 690S Substance abuse and public health

Department of Health Sciences and Health Promotion, University of Massachusetts Amherst

Role: Professor Graduate level – 10 students

Fall 2016,

Spring 2017

HS 101 U.S. health care delivery system

Health Sciences Department, California State University, Channel Islands (CSUCI) Role: Lecturer


Spring 2017

HS 301 Introduction to public health administration Health Sciences Department, California State University, Channel Islands (CSUCI)

Role: Lecturer


Fall 2015,

2016

Spring 2016

Physical and social aspects of substance abuse

Department of Psychology, Pierce College

Role: Lecturer Undergraduate level – 50 students

Summer 2009

Summer research program: Mentoring the next generation of behavioral health researchers Department of Psychiatry, UCLA

Role: Program director


Spring

2011, Fall

2016

Seminar on research methods and design (T32)

Department of Psychiatry, UCLA

Role: Guest lecturer Doctoral and post-doctoral level – 15 students

Spring

2015

Research training for international clinical scholars (Fogarty)

Department of Psychiatry, UCLA Role: Guest lecturer

Physicians, psychiatrists, psychologists – 10 students

1995 -

1999

English as a Second Language

Seoul, South Korea and Yokohama, Japan

Role: Instructor Adult language learners – 3 to 15 students per class

TEACHING – GUEST LECTURES, WORKSHOPS, INVITED TALKS

1. Evans, E. Intersections of public health and the criminal justice system: A focus on the opioid epidemic.

Invited talk given to Springfield Technical Community College, July 20, 2020.

2. Evans, E. Opioid epidemic and COVID-19. Invited talk given to Keene State College undergraduate students. October 5, 2020.

3. Evans, E. Opioid epidemic and in a pandemic. Invited talk given to Forbes Library. September 29,

2020. https://www.youtube.com/watch?v=TUgZtPV_SuY&t=1s

https://www.youtube.com/watch?v=TUgZtPV_SuY&t=1s


Page 22 of 29

4. Evans, E. Bridging the Gaps Through Research Partnerships: The Justice Community Opioid Innovation Network. Invited moderator and presenter at Comprehensive Opioid Abuse Program

(COAP) National Forum: United We Stand. March 20, 2020.

5. Evans, E. Interventions to address opioid use disorder and infectious disease in China. Guest lecture

given to University of Massachusetts Global Health students. March 4, 2020.

6. Evans, E. Funding your research. Research Scholar series. SPHHS, UMass Amherst. Invited talk given

to SPHHS faculty November 8, 2019. 7. Evans, E. The public health data warehouse: Models to inform and assess implementation. Invited talk

given to the Massachusetts Department of Public Health. October 31, 2019.

8. Evans, E. Addressing opioid use among criminally-involved populations: Opportunities for

collaboration with MassJCOIN. Invited talk given to the Public Forum on Opioid Use in Holyoke, MA, supported by the National Center for State Courts to the Trial Court. October 30, 2019.

9. Evans, E. Addressing opioid use among people involved with the criminal justice system. Invited talk

given to the Community Forum in Greenfield, MA supported by the Franklin Regional Council of Governments and the UMass Amherst Center for Community Health Equity. October 29, 2019.

10. Evans, E. The intersection of public policy, laws, opioid use, and treatment opportunities in the Opioid

Crisis. Guest lecture given to University of Massachusetts Health Promotion and Policy students. October 28, 2019.

11. Evans, E. Addressing opioid use disorders over the life course: A public health approach. Guest lecture

for UMass Amherst SPHHS Undergraduate Research Seminar. September 19, 2019.

12. Evans, E. Addressing the opioid crisis in small and rural communities in Western Massachusetts. Massachusetts Health Policy Forum, Brandeis University. September 6, 2019.

13. Evans, E. Public health and the opioid epidemic. Invited talk given to Springfield Technical

Community College, July 25, 2019. 14. Evans, E. Involving patient advocates in big data governance. Invited talk given to Learn2Cope -

Greenfield, July 16, 2019.

15. Evans, E. Involving patient advocates in big data governance. Invited talk given to Learn2Cope -

Holyoke, May 23, 2019. 16. Evans, E. A life course approach to addressing opioid use disorders among criminally involved

populations. University of Vermont Medical School, Grand Rounds. April 10, 2019.

17. Evans, E. Addressing opioid use disorders among criminally involved populations. UMass Amherst School of Public Policy Colloquia. April 1, 2019.

18. Evans, E. Preventing injury among adults with opioid use disorders. Guest lecture given to University

of Massachusetts Community Health Education students. March 26, 2019. 19. Evans, E. Women-specific strategies to support adherence to medications for opioid use disorder.

Providence Behavioral Health Hospital, Trinity Health of New England. March 20, 2019.

20. Evans, E. Treatment for opioid use disorder over the life course. Mayor and City of Burlington,

Vermont CommSTAT workgroup. December 20, 2018. 21. Evans, E., and Taylor, S.T. Gender Disparities in the Use of Complementary and Integrative Health by

U.S. Military Veterans w/ Chronic Musculoskeletal Pain. Cyberseminar hosted by VA Greater Los

Angeles Healthcare System, Health Service Research & Development (HSR&D), Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), November 29, 2018.

22. Evans, E. Applying a public health approach to address the opioid epidemic. Invited talk given to

Springfield Technical Community College, July 26, 2018. 23. Evans, E. Gender Differences in Cannabis Use Disorders: Preliminary Results from a Nationally

Representative Survey of U.S. Adults. Invited talk given to Marijuana Legalized: Research, Practice &

Policy Considerations. UMass Amherst, April 2, 2018.

24. Evans, E. Gender-specific causes and consequences of opioid use disorders. Invited talk given to Project ACCCES Maternal and Child Health Workgroup. UMass Springfield Center in Tower Square,

March 27, 2018.


Page 23 of 29

25. Evans, E. Public health approaches to address the opioid epidemic: Works in progress. UMass Amherst School of Nursing Spring Seminar Series, January 29, 2018.

26. Evans, E. Behavioral health effects of childhood adversity. Invited talk given to Strategic Planning

Initiative for Families and Youth (SPIFFY) Coalition on Creating a Trauma-Informed Hampshire

County. Northampton, MA, November 14, 2017. 27. Evans, E. Taking a public health approach to address opioid use, misuse, and overdose. Guest lecture

given to University of Massachusetts Health Policy and Management students. November 14, 2017.

28. Evans, E. Prospects of mining big data for research on opioids and other substance abuse. University of Massachusetts Amherst Computational Social Science Institute Seminar Series. Amherst, MA,

November 10, 2017.

29. Evans, E. Mining big data for opioid and other substance abuse research. Institute for Healthcare Delivery and Population Science, University of Massachusetts Medical School-Baystate. Springfield,

MA, November 1, 2017.

30. Evans, E. Prospects of mining big data for longitudinal substance abuse research. Symposium Invited

Chair: Electronic records-based research and applications. 2017 UCLA CALDAR Summer Institute and International Global Health Conference: Precision Research in Addiction, HIV, and Care.

Universal City, CA, August 15-17, 2017.

31. Evans, E. Adapting digital storytelling methods with and for homeless women Veterans to improve community integration by supporting self-management of substance abuse recovery. Work In Progress

(WIP) Seminar. VA Greater Los Angeles Healthcare System, Health Service Research &

Development (HSR&D), Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), May 11, 2017.Evans, E., Tips for securing a faculty position in health sciences. Invited

workshop given to pre- and post-doctoral fellows at UCLA ISAP T32 seminar, June 6, 2017.

32. Evans, E. Getting your research published. Invited cyberseminar workshop given to junior

investigators at VA Greater Los Angeles Healthcare System, Health Service Research & Development (HSR&D), Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), April

17, 2017.

33. Evans, E. Career development for junior investigators. Invited talk given to doctoral candidates in the Community Health Sciences Department, University of California Los Angeles, November 21, 2016.

34. Evans, E. Theoretical frameworks for understanding substance use disorders. Invited talk given to

Department of Psychology, Azusa Pacific University, October 1, 2015.

35. Evans, E. Emerging paradigms in substance use disorders and recovery. Invited talk given to Pierce College, Department of Psychology, July 28, 2015.

36. Evans, E. What can electronic health records tell us about the clinical course of patients with

cannabis use disorders treated in primary care settings. Workshop at College on Problems of Drug Dependence titled “Turning Electronic Health Records into Actionable Knowledge in Addiction

Research,” Phoenix, AZ, June 14, 2015.

37. Evans, E. Electronic health records and addiction research: Opportunities and challenges. Workshop at College on Problems of Drug Dependence titled “Turning Electronic Health Records into

Actionable Knowledge in Addiction Research,” Phoenix, AZ, June 14, 2015.

38. Evans, E. & Hall, E. Follow-up strategies for tracking and monitoring clients. UCLA CALDAR

Summer Institute on Longitudinal Research, Los Angeles, August 14, 2008. 39. Hser, Y.-I., Evans, E., & Huang, D. Short-term outcomes of Proposition 36 in five California counties.

California Hispanic Commission on Alcohol and Drug Abuse, Rosemead, California, November 4,

2005.

MENTORING

Internship director, 2020-

present

Holyoke District Court HEART Program, Judge William Hadley

Host site

New England Health Equity Program, 2020-2021 cohort


Page 24 of 29

Sponsor

NIH NIDA JCOIN LEAP fellowship for Ed Hayes

Sponsor NIH NIDA JCOIN LEAP fellowship for Susan Lemere

Doctoral students

Elizabeth Delorme (Fall 2020 - present) (PhD primary mentor) Kate Saunders (Fall 2020 - present) (PhD primary mentor)

Sophie Hermann (Fall 2019 - present) (PhD primary mentor)

Gene Garland (Fall 2019 - present) (PhD committee member) Paige Shaffer (Fall 2019 - Spring 2020) (PhD primary mentor)

Susan Lemere (Fall 2019 - Spring 2020) (PhD primary mentor)

Alice Fiddian-Green (Fall 2017 – Fall 2019) (PhD committee member) Kirk Sanger (Spring 2018 – Fall 2018) (PhD committee member)

MPH thesis committee

member

Marieflor Bauzon (Spring 2019)

Denise Leckenbury (Spring 2018)

Saloonie Adhikari (Chair, Fall 2019 - Spring 2020)

Devon Goldberg (Chair, Fall 2019 - Spring 2020)

Nidhi Malik (Fall 2019 – Spring 2020)

MPH advisor

Shannon Fox (Fall 2019-present)

Saloonie Adhikari (Fall 2019 - Spring 2020) Samantha Moore (Fall 2018 – Fall 2019)

Hind Aljarahi (Fall 2017 – Spring 2018)

Undergraduate advisor

Samuel Tarplin, BDIC Program (Fall 2018 – Fall 2019)

Monica Pabla, Public Health Honors College (Summer 2019 – Spring 2020)

Grace Coogan, Public Health Honors College (Spring 2020)

Independent study

supervision, undergraduates

Samantha Hano (Fall 2020)

Kene Orakwue (Fall 2020) Samuel Tarplin (Fall 2019)

Janie Xu (Fall 2019 – Fall 2020)

Isabella Izidoro (Fall 2019 - Fall 2020)

Makena Caron (Fall 2019 - Spring 2020) Grace Buckner (Spring 2020)

Emily Achuck (Spring 2020)

Independent study

supervision, graduate

students

Amelia Bailey (Fall 2020)

Devon Goldberg (Fall 2019)

Nidhi Malik (Fall 2019)

Sophia Neirman (Fall 2019)

SERVICE

UNIVERSITY SERVICE

Division and Department

2019-present Chair of Admissions, Community Health Education (CHE) Program

2020-present Member, Health Promotion and Policy (HPP) Department Personnel Committee (DPC)


Page 25 of 29

2017-present Member, Health Promotion and Policy (HPP) Department Committee 2017-present Member, Community Health Education (CHE) Program Committee

2020-present Member, Antiracism Workgroup, Health Promotion and Policy (HPP) Department

2017-2019 Member, Community Health Education (CHE) Doctoral Program Committee

2017-2019 Member, Community Health Education (CHE) Annual Faculty Report (AFR) Committee 2018 Co-founded with CHE faculty a new journal called "Narrative Public Health."

School of Public Health and Health Sciences (SPHHS) 2020 Public Health Council, representative for SPHHS, application in review

2020 Affiliated Faculty, Center for Justice, Law, and Societies, UMass Amherst

2019 Participant, SPHHS Dean Search Committee 2019 Reviewer, Faculty Research / Healy Endowment Grants

2018-present Adjunct Fellow, Center for Community Health Equity Research, SPHHS, UMass Amherst

2017-2018 Member, Ad-hoc Information Technology group

NIH NIDA JCOIN

Member, Steering committee

Member, Capacity Building Workgroup Member, Survey Advisory Group

Member, Publications and dissemination committee

Member, Equity, diversity, and inclusion committee Course developer, Mixed Methods Research Designs, NIDA JCOIN

UCLA

Trainer: local

07/03 – 12/03 Held 30+ trainings with substance abuse treatment providers in 7 California counties: Kern,

Los Angeles, Riverside, Sacramento, San Diego, San Francisco, and Shasta. Treatment System Impact and Outcomes of Proposition 36.

12/01 – 03/02 Conducted 24 county site visits and held 10 trainings on study protocols and

instrumentation in Alameda, Kern, Los Angeles, Mendocino, San Joaquin, San Mateo, Santa Barbara, Santa Clara, Shasta, and Ventura. Evaluation of the Substance Abuse and

Crime Prevention Act.

10/99 – 04/00 Held 30+ 2-day trainings on study protocols, instrumentation, and electronic data collection

in 13 California counties: Alameda, El Dorado, Kern, Lassen, Orange, Riverside, Sacramento, San Benito, San Diego, San Francisco, San Joaquin, San Luis Obispo, San

Mateo. California Treatment Outcome Project.

Trainer: national

06/28-06/29/11 Protocol training on the START Follow-up Study. National Institute on Drug Abuse, Clinical Trials Network. 60 attendees. Marina Del Rey Marriott, Los Angeles.

05/05/11 Strategies for re-contact of research participants. Web Seminar Series. National Institute on

Drug Abuse, Clinical Trials Network. Available at http://caldar.org/html/webinars.html.

Trainer: international

08/08 Data safety and monitoring. Changning Mental Health Center, Shanghai, China. 08/08 Data safety and monitoring. Yangpu District Mental Health Center, Shanghai, China.

08/08 Data safety and monitoring. Yunnan Institute for Drug Abuse, Kunming, China.

http://caldar.org/html/webinars.html


Page 26 of 29

Host of scientific conferences: local

10/99 California Substance Abuse Research Consortium. 200 attendees. Sacramento.

Host of scientific conferences: national

07/29/15 – 07/31/15 NIDA-sponsored UCLA CALDAR Summer Institute on Longitudinal Research.

100 attendees. Marina del Rey Marriott, Los Angeles. 08/13/12 – 08/15/12 NIDA-sponsored UCLA CALDAR Summer Institute on Longitudinal Research.

120 attendees. Marina del Rey Marriott, Los Angeles.

08/09/10 – 08/11/10 NIDA-sponsored UCLA CALDAR Summer Institute on Longitudinal Research &

Clinical Trials Network (CTN) Dissemination Conference. 170 attendees. Marina del Rey Marriott, Los Angeles.

08/13/08 – 08/15/08 NIDA-sponsored UCLA CALDAR Summer Institute on Longitudinal Research.

150 attendees. UCLA Covel Commons, Los Angeles. 02/12/07 – 02/13/07 NIDA-sponsored UCLA Asian American and Pacific Islander Conference and

Workshop: Translational Addiction Research: Bench, Bedside, Community, and

Back. 170 attendees. Doubletree Suites, Santa Monica. 08/13/06 – 08/14/06 UCLA CALDAR Summer Institute on Longitudinal Research. 150 attendees.

UCLA Covel Commons, Los Angeles.

Host of scientific conferences: international

04/22/15 – 04/24/15 NIDA-sponsored Biennial Meeting of the International Conference on Global

Health: Prevention and Treatment of Substance Abuse and HIV. 200 attendees. Hangzhou, China.

04/17/13 – 04/19/13 NIDA-sponsored Biennial Meeting of the International Conference on Global

Health: Prevention and Treatment of Substance Abuse and HIV. 365 attendees. Taipei, Taiwan.

PROFESSIONAL SERVICE

Professional memberships

Academy Health

American Anthropological Association (AAA)

American Public Health Association (APHA)

College on Problems of Drug Dependence (CPDD) 2019-2021 Member, Media Relations Committee, College on Problems of Drug Dependence (CPDD)

Editorial service

Editorial Boards:

2020-present Associate Editor, Journal of Substance Abuse Treatment (JSAT)

2016-present Associate Editor, Substance Use and Misuse

Reviewer for:

06/15-12/19 Addiction (6 reviews) 03/15-07/19 Addiction Research and Theory (4 reviews)

12/15-12/16 The American Journal on Addictions (2 reviews)


Page 27 of 29

8/16 American Journal of Preventive Medicine (AJPM) (1 review) 6/19-11/19 American Journal of Public Health (AJPH) (3 reviews)

08/19 BMC Health Services Research (1 review)

7/12 Clinical Child Psychology and Psychiatry (1 review)

9/20 Criminal Justice Review 7/14-05/17 Drug and Alcohol Dependence (DAD) (6 reviews)

09/17 Drug and Alcohol Review (1 review)

12/12 Elsevier Academic Press (1 review) 06/07 Evaluation and Program Planning (1 review)

3/14 Evaluation Review (1 review)

6/19 Journal of the American Medical Association (JAMA) (1 review) 3/12-7/12 Journal of Drug Issues (2 reviews)

11/19 Journal of General Internal Medicine (1 review)

6/15 Journal of Health and Social Behavior (1 review)

06/04-06/20 Journal of Psychoactive Drugs (4 reviews) 3/12-12/19 Journal of Substance Abuse Treatment (JSAT) (14 reviews)

7/16-3/17 Justice Quarterly (2 reviews)

2/19 Medical Decisionmaking (1 review) 10/16 Psychology of Addictive Behaviors (1 review)

07/17-8/20 Social Psychiatry and Psychiatric Epidemiology (3 reviews)

3/12-1/13 Substance Abuse Treatment, Prevention, and Policy Research (2 reviews) 3/16-7/17 Substance Use and Misuse (4 reviews)

Research Reviews

2019 Bohler, R. and The Heller School for Social Policy and Management, Brandeis University.

“Addressing the opioid crisis in small and rural communities in Western Massachusetts.”

2019 Spaulding, A and Emory University. Reviewer of LOI “Collaborative decision making in translational research for justice-involved persons who use opioids: On both sides of the jail fence.”

Submitted to Greenwall Foundation, July 1, 2019.

2019 Reviewer for Health Resources and Services Administration (HRSA), Division of Independent

Review (DIR), Federal Office of Rural Health Policy. June 27-28, 2019. 2019 Abstract reviewer for American Public Health Association (APHA) Annual Meeting.

2018 Goff, S. Proposal review, submitted to UMMS for Small Conference Grant. Funded.

2018 Abstract reviewer for American Public Health Association (APHA) Annual Meeting. 2018 Shaw, S. R01 abstract “Improving Medication Adherence with Pharmacist and Community Health

Worker Team (IMPaCT) to Reduce Disparities in Hypertension.” March 29, 2018.

2017 Poudel, K. R21 proposal “Tobacco cessation with PLHIV in Nepal.” Oct 27, 2017. 2017 Nickel, N. “Alcohol and associated health and healthcare burden in Manitoba” Manitoba Centre for

Health Policy, Department of Community Health Sciences, University of Manitoba. December 1,

2017.

COMMUNITY SERVICE

Advisor, Consultant

2020-present Member, Holyoke District Court Advisory Committee on Substance Abuse

2019 Advisor, Massachusetts Senator Joanne Comerford

2019 Advisor, Seattle/King County Jail, Health Services Program, Seattle, Washington 2019 Advisor to the Massachusetts Health Policy Commission, Brandeis University Opioid

Policy Research Collaborative


Page 28 of 29

2018 Consulting expert for Mayor & City of Baltimore v. Purdue Pharma L.P., et al., No. 24-C-18-000515, in the Circuit Court of Maryland for Baltimore City.

2018 Consulting expert for California Department of Corrections and Rehabilitation on

evaluation design for a new Young Adult Diversion Program

2018 Invited contributor to Congressman Jim McGovern's Opiate Addiction Roundtable 2013-present Member, UCLA Data and Safety Monitoring Board for Addiction Medicine (DSMBAM),

UCLA Department of Family Medicine

2010-2017 Academic advisor, Granada Hills Charter High School

MEDIA REPORTS

Commentaries/editorials on my research

Gyurina CH. (2020). Beyond parity: Medicaid policy and improving access to effective substance use disorder treatment. Medical Care. 58(2): 99-100.

Tetrault JM, Fiellin DA. (2017). Using a science-based approach to address the opioid epidemic. Annals of

Internal Medicine. E-pup ahead of print. doi:10.7326/M17-2854. Clausen T. Comment on Evans et al. (2015). Coherent long-term treatment approaches-superior in the

treatment of opioid dependence. Addiction. 2015 Jun;110(6):1006-7.

Degenhardt L, Mathers B, Hall WD. Response to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependence. Addiction. 2014 Aug;109(8):1335-7.

My research in the media

Krisberg, K. (May 24, 2013). Sending nonviolent drug offenders to treatment instead of prison saves

money. The Pump Handle. Retrieved from http://scienceblogs.com/thepumphandle/2013/05/24/

Office of National Drug Control Policy. (2013) National drug control strategy. Executive Office of the

President of the United States. Retrieved from http://www.whitehouse.gov//sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf

National Institute on Drug Abuse. (Feb 18, 2014). California reaped large savings by diverting drug-using

offenders into treatment. NIDA Notes. Retrieved from http://www.drugabuse.gov/news-events/nida-notes/2014/02/california-reaped-large-savings-by-diverting-drug-using-offenders-treatment

Recovery Research Institute, Massachusetts General Hospital and Harvard Medical School (August 14,

2014). Does neighborhood safety impact treatment outcomes. Harvard Center for Addiction Medicine Newsletter. Retrieved from

https://t.e2ma.net/webview/rx29m/257757bf48c160da07f307e677ca460c

Panelist for a Huffington Post Live discussion on “Hillary's $10B plan to fight addiction” (September 3,

2015) Retrieved from http://huff.lv/1O0Jdq1. Healy, M. (Nov 20, 2017). For opiate addiction, study finds drug-assisted treatment is more effective than

detox. Los Angeles Times. Retrieved from https://www-latimes-

com.cdn.ampproject.org/c/www.latimes.com/science/sciencenow/la-sci-sn-opiate-addiction-20171120-story,amp.html.

U.S. Department of Veterans Affairs (Jan 11, 2018). Childhood adversity and alcohol and drug use: Risks

Veterans should know. Vantage Point. Retrieved from https://www.blogs.va.gov/VAntage/44360/childhood-adversity-alcohol-drug-use-risks-veterans-

know/

New England Public Radio (Jan 12, 2018). Childhood adversity leads to higher substance abuse among

veterans. http://nepr.net/post/umass-study-childhood-adversity-leads-higher-substance-abuse-among-veterans#stream/0

http://scienceblogs.com/thepumphandle/2013/05/24/

http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf

http://www.drugabuse.gov/news-events/nida-notes/2014/02/california-reaped-large-savings-by-diverting-drug-using-offenders-treatment

http://www.drugabuse.gov/news-events/nida-notes/2014/02/california-reaped-large-savings-by-diverting-drug-using-offenders-treatment

https://t.e2ma.net/webview/rx29m/257757bf48c160da07f307e677ca460c

http://huff.lv/1O0Jdq1

https://www-latimes-com.cdn.ampproject.org/c/www.latimes.com/science/sciencenow/la-sci-sn-opiate-addiction-20171120-story,amp.html



https://www.blogs.va.gov/VAntage/44360/childhood-adversity-alcohol-drug-use-risks-veterans-know/

https://www.blogs.va.gov/VAntage/44360/childhood-adversity-alcohol-drug-use-risks-veterans-know/


Page 29 of 29

MassLive (Jan 12, 2018). Umass researcher finds women, male veterans have same rates of alcohol, drug abuse. Retrieved from

http://www.masslive.com/news/index.ssf/2018/01/umass_researcher_find_women_ma.html

ScienceNewsline (Jan 12, 2018). Women and men military veterans, childhood adversity and alcohol and

drug use. http://www.sciencenewsline.com/news/2018011211120085.html Top of Mind with Julie Rose (Feb 28, 2018). Military Veterans and Substance Abuse. Retrieved from

http://www.byuradio.org/episode/f1d9ed67-5ce1-4d2f-8450-

6a1c64bc45c1?playhead=2123&autoplay=true Daily Hampshire Gazette (April 3, 2018) Marijuana public health effects aired at UMass symposium.

Retrieved from http://www.gazettenet.com/umass-amherst-holds-symposium-on-marijuana-and-

public-health-16602050 Boston Globe (June 29, 2018). One in five Mass. adults consumed pot in past month. Retrieved from

https://www.bostonglobe.com/metro/2018/06/29/percent-mass-residents-consumed-marijuana-past-

days/XvyfXljy82S9HQv8mDd2IL/story.html

Daily Hampshire Gazette (July 4, 2018). UMass researchers contribute to key statewide marijuana study. Retrieved from http://www.gazettenet.com/UMass-researchers-play-large-role-in-state-s-marijuana-

study-18628738

WAMC Northeast Public Radio (Feb 25, 2019). UMass researcher to study opioid addiction treatment at two jails. Retrieved from http://www.tinyurl.com/yyn3zfcp

Daily Hampshire Gazette (Feb 25, 2019). Jails get grant for medication-assisted treatment. Retrieved from

https://www.gazettenet.com/OpioidSidebar-23684663 WGBY Connecting Point (Mar 5, 2019). Treating jail inmates for opioid use disorders Retrieved from

http://connectingpoint.wgby.org/franklin-county-jail-opioid-treatment-program-study/

AP News (July 27, 2019). UMass researchers get $10M grant to study opioid treatment. Retrieved from

https://www.apnews.com/e1f9234669aa49e68b391138503ef862 WGBY Connecting Point (August 12, 2019). Mass JCOIN. Retrieved from https://youtu.be/XZSYIK5vf1w

New England Public Radio (January 2, 2020). Gender differences should inform opioid treatment, says

study. Retrieved from http://www.tinyurl.com/w687lgk The HEAL Initiative. (Aug 5, 2020). Statewide Policy Changes in Massachusetts Could Lead to New Hope

for Treatment of Opioid Use Disorder in Jails Nationwide. Retrieved from

https://www.jcoinctc.org/massachusetts-hub-spotlight/

http://www.masslive.com/news/index.ssf/2018/01/umass_researcher_find_women_ma.html

http://www.byuradio.org/episode/f1d9ed67-5ce1-4d2f-8450-6a1c64bc45c1?playhead=2123&autoplay=true

http://www.byuradio.org/episode/f1d9ed67-5ce1-4d2f-8450-6a1c64bc45c1?playhead=2123&autoplay=true

http://www.gazettenet.com/umass-amherst-holds-symposium-on-marijuana-and-public-health-16602050

http://www.gazettenet.com/umass-amherst-holds-symposium-on-marijuana-and-public-health-16602050

http://www.gazettenet.com/UMass-researchers-play-large-role-in-state-s-marijuana-study-18628738

http://www.gazettenet.com/UMass-researchers-play-large-role-in-state-s-marijuana-study-18628738

http://www.tinyurl.com/yyn3zfcp

https://www.gazettenet.com/OpioidSidebar-23684663

http://connectingpoint.wgby.org/franklin-county-jail-opioid-treatment-program-study/

https://www.apnews.com/e1f9234669aa49e68b391138503ef862

https://youtu.be/XZSYIK5vf1w

http://www.tinyurl.com/w687lgk

https://www.jcoinctc.org/massachusetts-hub-spotlight/

Documents

Elizabeth Ayn Evans - UMass